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Articular cartilage provides an almost frictionless surface for the articulating ends
of the bone. Cartilage functions to lubricate and transmit compressive forces resulting
from joint loading and impact. If the cartilage is damaged, through traumatic injury or
disease, it lacks the ability of self-repairing as the tissue lacks vascular system. If the
injuries to articular cartilage are left untreated, they may progress to Osteoarthritis.
Osteoarthritis, a degenerative disease, is one of the leading disabilities in the United
States. Tissue engineering has the potential to regenerate healthy hyaline cartilage, which
can alleviate pain and restore the functions of normal tissue.
This study explores the production of engineered cartilage on top of composite
calcium phosphate scaffold. The current research is related to a biphasic approach to
cartilage tissue engineering — in which one layer supports to form subchondral bone
(osteogenesis) and another supports cartilage formation (chondrogenesis). Chondrocyte
and bone marrow-derived stem cell attachment to chitosan will be investigated for
producing a bilayered construct for osteochondral repair. The main objectives of my
research include the following: attachment and proliferation of human mesenchymal stem

cells on chitosan calcium phosphate scaffolds, techniques to create a biphasic construct,
the effect of coating chitosan calcium phosphate scaffolds with type I collagen and
determining the ideal bead size for making chitosan calcium phosphate scaffolds.
Keywords: cartilage, chitosan, osteochondral defects, tissue engineering
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INTRODUCTION

Treatment of articular cartilage injuries is challenging because the tissue has
limited capacity of intrinsic healing due to lack of blood vessels. This study explored one
approach to cartilage tissue engineering, whereby cartilage forms in vitro on top of
biodegradable composite chitosan-calcium phosphate (CHI-CaP) scaffolds. CHI-CaP
microbeads were fused to make cylindrical scaffolds of approximately 35% porosity. The
scaffold supports bone ingrowth and provides a platform for cartilage formation. Stem
cells or chondrocytes were seeded onto the scaffolds at such high densities that they
produce a layer of cartilage through self-assembly. These experiments have demonstrated
the efficiency of cell adhesion, rate of proliferation, the influence of cell seeding
technique, the effects of coating scaffolds with type I collagen, and also the effects of
bead size. Coating the scaffolds with collagen made them more hydrophilic and increased
cell attachment and chondrogenesis. It also facilitated formation of a continuous layer of
hyaline-like cartilage over the area of cell seeding. CHI-CaP scaffolds also showed
biocompatability and mineral deposition when seeded with osteosarcoma cells. These
studies indicate the potential for creating a bilayered construct consisting of an
osteoconductive CHI-CaP phase and a tissue-engineered cartilage phase.
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1.1

Articular Cartilage
Articular cartilage, also known as hyaline cartilage, is one of the three types of

cartilage found in the human body. It is the smooth, white tissue that covers the articular
surface of bones in synovial joint. It decreases friction, absorbs shock, distributes load
and provides a smooth lubricating surface for easy joint movements. This cartilage tissue
is susceptible to injury through a number of mechanisms, including trauma (e.g., patellar
dislocation or hyperflexion) and congential anatomical abnormality. Articular cartilage is
devoid of blood vessels, lymphatics and nerves. The normal wound healing process is not
provoked by blood cells and the tissue has a limited capacity of intrinsic healing due to
the absence of vascular system [1]. Therefore, if the injuries to articular cartilage are left
untreated, it would advance to osteochondral defects and lead to osteoarthritis.
Osteoarthritis (OA) is one of the leading disabilities in United States. A long standing
therapy for treating OA is not yet available. The treatment and repair of articular cartilage
is quite challenging due to its complex architecture. The emerging field of cartilage tissue
engineering shows promising results in regenerating healthy hyaline cartilage, which can
alleviate pain and restore the functions of normal tissue. Basic composition, structure,
and functions of the articular cartilage need to be studied to regenerate healthy tissue.
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Figure 1.1

Diagram showing a healthy knee joint

(Courtesy - http://www.niams.nih.gov/Health_Info/Osteoarthritis/)
1.1.1

Composition
Articular cartilage is mainly composed of water, collagen and proteoglycans and

its composition varies with depth, which influences the mechanical behavior of the tissue
[1,2]. Articular cartilage also has cells known as chondrocytes, which are surrounded by
an extracellular matrix (ECM). Chondrocytes are spherical shaped cells and do not
exhibit any cell-to-cell contact (Figure 1.2) [3]. The material parts other than
chondrocytes in a cartilage tissue constitute ECM. The structure and composition of
ECM dictates tissue mechanics and also influences cell differentiation, migration, and
cellular synthesis. The ECM of articular cartilage is primarily proteoglycan and collagen.
The high concentration of proteoglycan creates osmotic pressure and chemical expansion
stress (due to high negative fixed charge density), which contributes to the tissue’s
3

compressive resistance and maintains water content of approximately 80% of the total
wet weight of the tissue. In cartilage tissue type II collagen accounts for 90% to 95% of
the total collagen content. Collagen is a structural protein and it helps in providing tensile
strength to cartilage.

Figure 1.2

Articular cartilage tissue showing chondrocyte, collagen, GAG, and water
molecules.

(Courtesy www.bidmc.org/Research/Departments/Radiology/Laboratories/Cartilage.aspx)
Chondrocytes are the sparsely spread cells found in cartilage. They are about 1%
in volume in adult human articular cartilage [2]. Chondrocytes play an important role in
4

the production and maintenance of extracellular matrix in cartilage tissue. They are
derived from mesenchymal stem cells (MSC) from matured bone marrow. MSCs
differentiate into chondrocytes during embryogenesis and develop extracellular matrix
[3]. Although chondrocytes vary in size, shape, and metabolic activity in various zones of
cartilage, cells contain organelles necessary for synthesizing extracellular matrix.
Spheroidal shaped mature chondrocytes also synthesis type II collagen, large aggregating
proteoglycans, and specific noncollagenous proteins. As the cartilage tissue lacks
vascular system, it relies on chondrocytes for the exchange of nutrients and waste
material.
Proteoglycans are macromolecules found in the extracellular matrix of the
cartilage tissue. Proteoglycans contribute to 25%-35% of the total dry weight of the
articular cartilage tissue. Proteoglycans consists of a core protein covalently attached to
one or more polysaccharides called glycosaminoglycans (GAG) (Figure 1.3). Chondritin
sulfate and keratin sulfate are the two main types of GAGs present in cartilage
extracellular matrix. Functions of the proteoglycans include but are not limited to
lubricants that absorb water, shock absorbers that resist compression, and also regulate
diffusion and flow of both water and macromolecules.

5

Figure 1.3

Molecular organization of a proteoglycan aggregate molecule

(Courtesy - www.marvistavet.com/html/normal_joint_structure.html)
Collagen, a structural protein, accounts for 60% of the dry weight of the cartilage
[2]. Collagen is made up of repeating chains of amino acids which form a triple helical
structure. Cartilage has an abundance of type II collagen and other types are present in
much smaller amounts. The structure of the cartilage is due to the collagen fibrillar mesh
work present in the extracellular matrix. Collagen provides mechanical strength, carries
tension, provides a platform for bone mineralization, and supports attachment for
numerous cells.
6

Figure 1.4

1.1.2

Macro to nano scale organization of an articular cartilage tissue [4]

Structure
Chondrocytes regulate the arrangement of collagen, proteoglycan, and all other

proteins into a unique and systemized order to form an articular cartilage [2]. The
arrangement, configuration, mechanical properties, and metabolic activity of the tissue
vary with depth. The cartilage tissue region starting from the articular surface to the sub
chondral region is divided into four zones. They are tangential (or superficial),
transitional (or middle), radial (or deep), and calcified cartilage zones (Figure 1.5). These
zones vary in the concentrations of water, proteoglycan, and collagen. Chondrocytes in
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each zone vary in volume, architecture, and orientation with respect to the articular
surface.

Figure 1.5

Structure of articular cartilage

A) chondrocyte organization in different zones of an articular cartilage B) Collagen fiber
orientation [1]
The superficial, also known as tangential, zone is the outer covering layer of the
cartilage that forms the articulating surface for joint movements. It is the thinnest of all
the zones in articular cartilage. It has parallel arrangement of small diameter collagen
fibers and elongated (or flattened) chondrocytes with respect to articular surface. These
parallel collagen fibers provide tensile strength to the tissue to withstand joint forces. It
also has condensed collagen fibers and sparsely arranged proteoglycans, which make it a
highest water content zone. This is the only zone in which articular cartilage progenitor
cells can be found. The cells in this region are covered with a layer of lubricin which
helps in easy joint movements and helps to avoid wear and tear of the tissue due to
frictional forces. Superficial zone is a crucial layer of cartilage, and its loss has shown to
8

increase ECM permeability and deformation, which is mostly seen in the early stages of
osteoarthritis [5].
The middle, or transitional, zone is the thickest of all the four zones, constituting
about 40%-60% of the total tissue thickness. Collagen fibrils having large diameter
compared to those in superficial zones are oriented randomly in middle zones.
Chondrocytes attain a more spherical shape and the ECM has abundant proteoglycans,
limited collagen and water in this zone. Presence of more proteoglycan helps the middle
zone to withstand compression.
The deep or the radial zone constitutes about 30% of the total tissue thickness.
This layer contains large diameter collagen fibrils, highest proteoglycans, and the lowest
water content. Chondrocytes in this zone are round in shape and are arranged in columns
parallel to the collagen fibrils and perpendicular to the articular surface. This zone holds
the largest collagen fibrils and the highest amount of proteoglycans of articular cartilage
[6].
Calcified cartilage is the last zone of articular cartilage and sits on top of a
subchondral bone. Tidemark, a borderline, separates the deep zone from the calcified
zone. The cells in this zone are smaller, covered by ECM and have less metabolic
activity. The large collagen fibers present in the deep zone penetrate into calcified zone
and eventually ends in subchondral bone, providing a connection between cartilage and
bone.
1.1.3

Functions
Articular cartilage surrounding the articular surfaces of a bone provides cushion

like surface for easy, painless joint movements. The tissue has a unique composition and
9

characteristic: it attributes to the mechanical properties of articular cartilage, which
makes it able to withstand weight without disrupting the cartilage. It also helps in shock
absorption because of its flexible nature.
Nancy S et al. related the articular cartilage to the mixtures theory, as a mixture of
four elements which can constitute into two phases – the fluid phase and the solid phase.
The fluid phase is composed of all the interstitial fluid that is free to move and the solid
phase is comprised of fibrous network of collagen, proteoglycan, and lipids. The
interstitial fluid in the extracellular matrix is reorganized in the presence of mechanical
loads, which results in viscoelastic behavior. Viscoelastic behavior of the articular
cartilage is mainly due to the fluid flow through the pores and due to the rate of
deformation of solid components (Figure 1.6) [7]. Joseph N Mansur proposed that
articular cartilage is similar to a sponge, even though fluid does not pass through it freely.
For modeling cartilage, the fluid phase is taken as an incompressible and inviscid,
whereas the solid phase is taken as an elastic material [8].

10

Figure 1.6

Diagram shows the different forms of lubrication when load is applied to
the articular cartilage tissue. [7]

When a mechanical load is applied to the cartilage, chondrocytes respond to it and
regulate several functions such as growth, cellular differentiation, and metabolism.
Certain types of mechanical load also cause damage to the cartilage tissue (Figure 1.7).
Chondrocyte apoptosis can also be seen when tissue is loaded under high levels of
magnitude and strain.

11

Figure 1.7

1.2

Effects on chondrocyte functions upon loading [9]

Articular cartilage damage
Traumatic or mechanical degeneration (wear and tear) of the joint can lead to

articular cartilage injuries, which is the loss of cartilage tissue in the joint. Unfortunately,
cartilage tissue is not capable of self-healing. If these cartilage defects are left untreated,
they expand and damage the surrounding healthy hyaline cartilage. Articular cartilage
defects are usually classified into two types – osteochondral or full thickness defect and
chondral or partial thickness defect (Figure 1.8). The cartilage defects limited to the
cartilage region are known as partial thickness defect or chondral defect, whereas the
defects that penetrate the subchondral bone are known as full thickness defect or
osteochondral defect. The defects confined to the cartilage region, chondral or partial
thickness defects results in the disruption of collagen arrangement and GAG. As the
cartilage tissue lacks blood vessels, the chondral defects cannot initiate self-repair
process. In case of osteochondral or full thickness defects, as the defect reach the
12

subchondral bone, self-repair process is initiated as the blood cells and undifferentiated
mesenchymal stem cells make their way to the defect. This leads to the formation of a
scar or fibrous cartilage in the defect region [10]. Fibrous cartilage is the toughest among
the three types of cartilages. This tissue cannot form a continuous cartilage and cannot
perform all the functions of a native hyaline cartilage. Instead of alleviating pain, this
formed fibrous cartilage increases pain and may advance to osteoarthritis.

Figure 1.8

Schematic representation of Osteochondral (or full- thickness) and
Chondral (or partial thickness) defects [11]
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Osteochondral defect or full thickness defect is graded on a scale from stage 1 to
5 based on the stability and severity of the injury from MRI findings. Stage 1 is limited to
articular cartilage injury, where a small rupture of cartilage is noticed. At stage 2, the
injury spreads to the subchondral bone, but damaged cartilage is still intact to the
subchondral bone. In the next stage, the cartilage defect gets separated from the bone. In
the fourth stage, these damaged osteochondral fragments were dislocated in the joint
causing severe pain. The last stage was evidenced by the formation of subchondral cysts
in the joint. There is no study to date that showed the advancement of osteoarthritis from
subchondral cysts but, these subchondral cysts were observed in osteoarthritis patients
[12,13,14].
Osteoarthritis (OA) is a degenerative joint disease and mostly seen among older
people (severity advances with age) or in athletes after injuries. 15% (40 million) of
Americans had some form of arthritis in 1995 and it is estimated that 18.2% (59.4
million) of Americans will be diagnosed with arthritis by 2020 [4]. OA damages the
exterior layer of cartilage, breaks and wears it away. Due to this, the bones lying below
the cartilage defect rub together during joint movements. This rubbing together causes
pain, swelling, and finally results in loss of joint movement. If these damages are not
fixed, the joint may be deformed and also small deposits of bone called osteophytes (or
bone spurs) grow in the joint causing more pain and damage (figure 1.9).

14

Figure 1.9

Diagram showing healthy and osteoarthritis knee joint

(Courtesy - https://www.nlm.nih.gov/medlineplus/ency/imagepages/17103.htm)
1.3

Current treatment options for cartilage defects
There is no permanent cure for osteochondral lesions to date and this treatment in

young patients is more challenging as they engage in higher levels of physical activity.
As the cartilage tissue is devoid of blood vessels, this tissue lacks the capacity of intrinsic
healing. Various treatment options are now available for treating damaged cartilage. In
most of the current therapies, either cells capable of chondrogenic differentiation are
implanted in the defect site or blood supply is allowed from subchondral bone to the
defect site to initiate healing process. In most of the cases, it results in the formation of
15

fibrous cartilage. This formed fibrous cartilage can alleviate joint pain but cannot perform
all the functions of an articular cartilage. The present-day surgical treatment approaches
to the damaged cartilage depends on the size and severity of the lesions [15] (Figure
1.10).

Figure 1.10

Current treatment paradigms for articular cartilage degeneration

Diagram showing the current treatment paradigms for articular cartilage degeneration
depending on size and severity of the defects. [15]
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1.3.1

Microfracture
Microfracture is most commonly performed for focal lesions with <2cm2.

Microfracture is a treatment option in which the damaged cartilage is removed and small
holes are created deep inside the bone to allow blood cells to migrate to the injury site.
These holes of approximately 2 mm in diameter and separated by 3-4 mm are created
using a specially designed 45° bent awl (Figure 1.11). Microfracture has a good success
rate with best long lasting results in young and less active patients with smaller defect
site.

Figure 1.11

Schematic representation of microfracture process

A) removal of dead or damaged articular tissue B)calcified cartilage removal C)
microfractures created using 45° bent awl D) Mesenchymal clot in the defect site for
cartilage repair [16].
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1.3.2

Chondroplasty
Microfracture and chondroplasty are the most commonly performed therapies to

treat articular cartilage lesions [5]. Chondroplasty is the process of reshaping the joint
surface by removing the damaged cartilage and stimulating the underlying
undifferentiated cells to cover the damaged area with fibrocartilage. In most of the cases
when chondral defects reach the bone, a scar tissue formed with fibrocartilage fills the
defect. This fibrocartilage is more dense compared to articular cartilage and cannot
perform functions as articular cartilage. These therapies are available to young patients
with small lesions and with only limited success rate.
1.3.3

Mosaicplasty
Mosaicplasty is a surgical procedure followed to resurface the cartilage defects

ranging between 2-3 cm2 in size. In this process, autologous osteochondral grafts are
harvested from a low weight bearing regions of the knee. After removing the damaged
cartilage, these grafts are implanted in the defect region in a pattern that it covers the
defect site. The main advantages of this procedure include autologous grafts which
reduce the infection and can be performed as a single surgical procedure. The limitations
of this procedure are limited availability of grafts, fitting the graft in defect site, and
morbidity in the donor site [17]. As the hyaline cartilage itself is implanted directly in the
defect site, mosaicplasty is preferable than autologous chondrocyte implantation, where
chondrocytes are implanted in the defect region.
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Figure 1.12

Diagram showing the process of Mosaicplatsy where autologous
osteochondral grafts were implanted in defect site.

(Courtesy: http://boneandspine.com/mosaicplasty-or-osteochondral-graft-transfer-system)
1.3.4

Autologous Chondrocyte Implantation
Autologous Chondrocyte Implantation (ACI) is usually performed for a defect

size ranging between 3-4 cm2. ACI is another option for treating cartilage defects. In this
process, chondrocytes are isolated from a healthy cartilage harvested from a low weight
bearing region. After expanding these chondrocytes, a second surgery will be performed
where these cells will be implanted in the defect site and sealed with periosteal flap. The
final results of ACI have shown formation of hyaline like tissue in the defect region and
there is also pain relief and restored joint function in 80-90% patients [6]. But the main
drawbacks of ACI are chondrocyte leakage from the defect region, uneven distribution of
chondrocytes and periosteal hypertrophy [7].
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Figure 1.13

1.3.5

Schematic representation of Autologous Chondrocyte Implantation (ACI)
[11]

Osteochondral grafts (allografts)
Osteochondral allograft is a procedure similar to mosaicplasty where

osteochondral plugs are implanted in the defect region. This differs from mosaicplasty by
collecting the osteochondral grafts from a different donor rather than from same patient
as in mosaicplasty. The main advantage of this procedure is that grafts can be collected
from the same site of defect from donor so that it can fix well in the defect place. Grafts
can also be collected from a young donor. The main drawbacks are the immune response
and disease transmission from the donor.
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1.3.6

Total knee replacement
Total knee (joint) replacement or total knee arthroplasty (TKA) is the only option

at the end stage of cartilage damage and there is only a 50% chance of good outcome
[18]. Knee replacement is a surgical procedure where the damaged ends of femur and
tibia bones will be replaced with a metal [19]. The artificial parts that are used are called
prosthesis. The clinical outcome results of patients’ undergone total hip replacement will
start to gradually decline starting from 5 years after surgery and infection is the most
common cause for failure [20].

Figure 1.14

Diagram showing a healthy knee joint and a total knee replacement

(Courtesy: https://www.nlm.nih.gov/medlineplus/kneereplacement.html)
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1.4

Tissue Engineering
The loss or failure of an organ or tissue is one of the most frequent, disastrous,

and costly problems in human healthcare. A new field, tissue engineering, applies the
principles of biology and engineering to the development of functional substitutes for
damaged repair [21]. There are two main components in tissue engineering – cells to
regenerate the lost or damaged tissue and scaffolds (or matrices) that allow cell
attachment and tissue growth. Tissue engineering is quite challenging where the
engineered tissues should contain the ECM components of the target native tissue in
similar proportions and structural arrangements and also provide similar biomechanical
functions. In a cartilage tissue engineering approach, cells were either encapsulated in or
seeded on top of a three dimensional scaffold materials. The main goal of cartilage tissue
engineering is to regenerate healthy hyaline cartilage in vitro and implant the tissue in
vivo which functions similarly to the native articular cartilage.
Cell performance and ease of access are the two main specifications that need to
be examined while selecting cells for cartilage repair. Different cell types including
chondrocytes, mesenchymal stem cells, embryonic stem cells, and pluripotent cells have
been considered for cartilage regeneration (Table 1.1). Articular chondrocytes and MSCs
are the most commonly used cell sources for cartilage tissue engineering. MSCs have
some advantages compared to chondrocytes, chief among them being the preservation of
all healthy cartilage in the affected joint and sparing of additional trauma to that joint
[22]. MSCs are hypoimmunogenic, self-renewable, and can also proliferate for long
periods [23]. They also exhibit anti-apoptotic and wound healing properties [24]. MSCs
are easy to harvest and can differentiate into chondrocytes when supplied with growth
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factors like transforming growth factor –β1. Chondrocytes have limited potential for
expansion in vitro, and proliferation in monolayer results in cell de-differentiation and
declining chondrogenic potential [25] [26].
Table 1.1

Advantages and Disadvantages of various cell types for cartilage tissue
engineering [27]

Scaffolds provide a matrix for cell attachment in tissue engineering. Things need
to be considered before selecting a scaffold are mechanical integrity, biocompatibility,
cell attachment, degradation rate, and degradation products. Biological and synthetic
based scaffolds can potentially enhance to repair or replace any tissue in musculoskeletal
tissue engineering [28]. Biologically derived scaffolds are acellular tissue scaffolds
(Collagen, hyaluronic acid, and chitosan) and have a limited capacity of modification.
Synthetic polymer based scaffolds enable the design of scaffolds with specific
mechanical and biological properties. However, the scaffold must be strong enough to
provide support to the defect site until the formation of new bone. Sustained release of
growth factors to promote bone growth is desirable in addition to providing a structure to
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which bone cells can attach [29]. Scaffolds structurally reinforce the defect to maintain
the shape of the defect and to prevent the distortion of surrounding tissue.

Figure 1.15

Overview of engineered cartilage on CHI-CaP scaffolds for osteochondral
defects approach.

The osteoconductive scaffold we have selected for this study is made up of
calcium phosphate in a chitosan matrix. Chitosan is a deacetylated derivative of chitin,
found in the exoskeleton of marine crustaceans. Chitosan is a biocompatible and
osteoconductive polymer with enhanced wound-healing capability [30]. Also
antimicrobial properties of chitosan could reduce the bacterial infection upon
implantation [31,32]. Chitosan is biodegradable and even the oligosaccharide degradation
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products, liberated primarily by enzymatic hydrolysis of the acetylated residues, does not
cause any damage.
Tissue engineering, a relatively new field, studies the formation of new perfectly
functional tissues and organs by combining cells, biomaterials and biological factors that
can be implanted in the defect region. Cartilage tissue when implanted by itself, do not
easily secures to the underlying bone and the surrounding native cartilage. Cartilage is
much more easily immobilized in the joint when it is attached to the scaffold and then
press fit into a bony defect. Most often the subchondral bone lying below the articular
cartilage defect also undergoes degeneration. It is important to repair the subchondral
bone along with cartilage defect as it provides support and integrates with neocartilage
[33]. The current research is a biphasic approach to cartilage tissue engineering, in which
one layer supports to form subchondral bone (osteogenesis) and another support cartilage
formation (chondrogenesis).
1.5

Motivation and Specific aims
Cartilage of the knee is frequently injured, often as a result of sports related

trauma, but focal articular cartilage lesions do not heal spontaneously. Articular cartilage
is avascular, and the chondrocytes adjacent to an injury do not proliferate or migrate into
the defect. Thus the tissue has very limited capacity for intrinsic repair, and untreated
focal cartilage lesions may progress to early osteoarthritis [34]. Furthermore, such defects
are associated with pain, swelling, and functional deficit [35].
Focal chondral lesions are a common finding during arthroscopy. A large review
of 25,124 knee arthroscopies performed from 1989 to 2004 showed that isolated cartilage
lesions occurred in 18% of patients [36]. According to current clinical guidelines, patients
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with an ICRS (International Cartilage Repair Society) grade III or IV chondral lesions
who are under 40 years of age may be good candidates for a restorative procedure [37].
Such patients accounted for 7% of all cases in the aforementioned review. Thus grade III
and IV focal chondral lesions occur in a sizeable population of relatively young patients
who might benefit from hyaline cartilage restoration.
Due to the limited availability of self-healing, it motivated many researchers to
regenerate healthy hyaline cartilage using tissue engineering. We propose a new
treatment alternative for focal chondral lesions using a biphasic construct of autologous
cartilage and an osteoconductive scaffold. Autologous mesenchymal stem cells isolated
from a bone marrow or adipose tissue biopsy will be expanded in monolayer and seeded
on top of a porous chitosan-calcium phosphate so as to form a scaffold-free layer of
cartilage adhered to the beads of the scaffold. This biphasic constructs will then be
implanted into an osteochondral defect. The scaffold is expected to facilitate attachment
to the native bone and will initially serve to transmit joint forces to the underlying bone.
The scaffold is biodegradable and is replaced by host bone, thereby restoring the tissue
structure and mechanics of a healthy joint.
The current investigation was relevant to the regeneration of cartilage in
osteochondral defects, a treatment which may prevent or delay osteoarthritis.
The first specific aim of this proposal deals with cell attachment and
proliferation of mesenchymal stem cells on chitosan calcium phosphate (CHI-CaP)
scaffolds. The long term aim of this proposal was to develop an osteochondral construct
with engineered cartilage. In order to achieve this aim, first and fore most things to
achieve was MSC attachment to CHI-CaP scaffold. The porous nature of the
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chitosan/CaP scaffold facilitates anchorage for the formation of cartilage. These scaffolds
have adequate mechanical strength and toughness and their degradation products were
not cytotoxic. This study showed that bone marrow derived MSCs can attach and
proliferate on CHI-CaP scaffolds.
In the second specific aim of this study, biphasic constructs were prepared using
two different approaches to determine which approach would yield a better construct.
The typical bilayered construct consists of two different scaffold materials fused together
or two different cell types seeded on top and bottom halves of the scaffold. In our
approach, neocartilage (chondrogenesis) was formed from MSCs by self-assembly on top
of osteoconductive CHI-CaP scaffold (osteogenesis). In this aim two different approaches
for creating biphasic constructs were evaluated based on tissue formation, SEM, and
histology.
The third specific aim, of this proposal was to determine how scaffold porosity
and collagen coating would affect the bonding between engineered cartilage and scaffold.
In order to improve tissue-scaffold integration, scaffolds were coated with type I
collagen, an extracellular matrix protein to which cell attachment was mediated by
integrin receptors. This study suggests that MSC attachment to a collagen precoated
scaffold leads to biphasic construct fully covered with neocartilage.
The fourth specific aim was to identify the best bead size to make the composite
CHI-CaP scaffolds for osteochondral defects. The size of the beads wasvaried by the
droplet size of the chitosan solution dropping into precipitate solution. Pore size affects
the penetration depth of cells and thereby tissue formation. Porosity, swelling ratio,
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mechanical testing, and degradation tests were performed on different bead size scaffolds
to identify the ideal bead size.
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ATTACHMENT AND PROLIFERATION OF HUMAN MESENCHYMAL STEM
CELLS ON CHITOSAN CALCIUM PHOSPHATE SCAFFOLDS

2.1

Introduction
The purpose of this study was to conduct a preliminary investigation using a

tissue engineering approach to osteochondral regeneration using composite chitosan
calcium phosphate scaffolds and MSCs.
Chitosan is a deacetylated derivative of chitin found in the exoskeleton of marine
crustaceans (Figure 2.1) and is the second largest biological polymer. Chitosan is one of
the widely used scaffold materials for tissue engineering. It is a polysaccharide chain
made up of N-acetyl-D-glucosamine and D-glucosamine linked by β(1-4) bands (Figure
2.2). Chitosan has been widely used in various biomedical applications such as tissue
engineering, wound dressing, drug delivery, and cancer diagnosis [1]. Previous research
also revealed that chitosan has hemostatic and cholesterol lowering properties [2].
Furthermore the material properties of chitosan can be regulated by varying the molecular
weight and degree of deacetylation (DDA) [3,4,5]. Chitosan is a biocompatible and
biodegradable scaffold material. Biodegradable polymers are applicable to those tissue
engineering products in which tissue repair is the goal, but not where long-term materials
stability is required. The degradation rate of chitosan depends on the DDA, where the
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chitosan with lower DDA degrades faster [6]. Chitosan dissolves in acidic solutions with
lower pH value.

Figure 2.1

Extraction of chitosan from Shellfish wastes from food processing [7].
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Figure 2.2

Chemical Structure of chitosan [7].

Pore size and porosity of chitosan scaffolds are approximately 100-800 µm and
35% and is sufficient for ingrowth of new tissue [6]. This porosity of the scaffolds was
created by fusing small beads together by briefly washing with acetic acid. According to
Chesnutt et al. the compressive modulus of theses scaffolds was 10MPa and can also
undergo 50% compressive strain without breaking scaffold [6]. Compressive loading
causes some matrix consolidation and fluid flow out of the tissue in the regions closest to
the articular surface, which contributes to joint lubrication. Under loading for short
duration, the tissue in the deeper region adjacent to bone experiences almost no
deformation as load is supported by interstitial fluid pressure.
Previous investigations done by Chesnutt et al. have shown that CHI-CaP
scaffolds support cell attachment and proliferation of human fetal osteoblast cells and
human embryonic palatal mesenchymal cells [6,8]. Cell attachment and viability of
human umbilical cord stem cells on calcium phosphate cement chitosan scaffolds was
shown by Liang Zhao et al. [9]. Oliveira et al. had shown the attachment of goat bone
marrow stromal cells seeded on hydroxyapatite/chitosan bilayered scaffold [10]. The
current study investigates the human bone marrow mesenchymal stem cell attachment
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and proliferation on composite chiotsan calcium phosphate scaffolds (CHI-CaP) prepared
by co-precipitation method.
2.2
2.2.1

Methods
Scaffold fabrication
Composite CHI-CaP beads were prepared by co-precipitation method as

described previously by Chesnutt et al. [6]. Chitosan solution was prepared by dissolving
3.57gm of 78.7% DDA chitosan powder (Vanson Halosource, Remond, WA) in 84 ml of
2 wt% acetic acid. 10 ml of 1 M CaCl2 in 2% acetic acid and 6 ml of 1 M NaH2PO4 in
2% acetic acid was added to the chitosan solution to make a final Ca:P ratio of 1.67. The
chitosan calcium phosphate solution was left for overnight on stirrer to get a nice
consistent solution. The consistent chitosan solution was taken into a 30 ml syringe with
18G needle and was fixed to a syringe pump. The chitosan solution was added drop wise
into a magnetically stirring precipitate bath at a rate of 15ml per hour (Figure 2.3). The
precipitation solution was made of 20% NaOH, 30% methanol, and 50% DI water at a
pH 13. These drops were precipitated into beads eventually. The beads were left in
precipitate solution for 24h for the formation of crystalline hydroxyapatite, bone mineral
as proposed by Rusu et al. as shown in Equation 2.1[11]. After 24 hours the precipitation
solution was replaced by DI water. These beads were washed regularly in DI water until
it reaches pH 7.
10𝐶𝑎𝐻𝑃𝑂4 + 12𝑂𝐻 − → 𝐶𝑎10 (𝑃𝑂4 )6 (𝑂𝐻)2 + 10𝐻2 𝑂 + 4𝑃𝑂43−

(2.1)

+𝐴𝐶𝑃 + 𝑂𝐻 − → 𝐶𝑎10 (𝑃𝑂4 )6 (𝑂𝐻)2

(2.2)
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The beads were then separated individually into a large dish and air dried
overnight at room temperature as shown in figure 2.4. These beads reduced to almost
60% of its original size after drying. Dried beads were packed into custom made
cylindrical molds. This consists of two separate plates, where the bottom plate was flat
with no holes and the top plate has cylindrical shaped holes of 6.5mm diameter × 7mm
height (Figure 2.5). While making scaffolds these plates were wiped to dry and taped
together so that they will not deform scaffolds. The dried beads were filled into the holes
and fused into scaffolds by brief exposure to 1% acetic acid and manually applied
pressure (Figure 2.6). The leftover acetic acid was washed using DI water and allowed
them to dry at room temperature for 24 hours.
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Figure 2.3

Chitosan calcium phosphate solution dripping drop wise into a
magnetically stirring precipitate bath at a rate of 15ml per hour.
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Figure 2.4

CHI-CaP beads separated individually into a dish and air dried overnight at
room temperature.

These scaffolds were then washed in 70% ethanol for 2 hours at room temperature
and allowed them to sit at room temperature for 1 hour. All the CHI-CaP scaffolds were
then frozen at -20°C for 2-3 hours and lyophilized overnight. Previous study has shown
that lyophilization enhances porosity, surface texture and protein absorption [12]. All
these lyophilized scaffolds were collected into sterile pouches for ethylene oxide gas
sterilization before seeding cells.
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Figure 2.5

2.2.2

Two separate plates – one having cylindrical shape holes for scaffold
fabrication to be place on top of the other flat plate.

Scaffold mechanical testing
The compressive modulus of cell-free scaffolds was measured. One of the main

functions of bone in in vivo is load bearing. As these CHI-CaP scaffolds are replacing a
bone part in a joint, they need to have load bearing capacity similar to native bone. In
order to measure the compressive modulus, the scaffolds were first incubated for 1, 14, or
28 days in cell culture medium at 37°C. Young’s modulus in the axial direction was
determined by unconfined compressive loading at 5 μms-1.
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Figure 2.6

2.2.3

CHI-CaP beads filled into cylindrical shape molds and fused together using
2% acetic acid.

Cell source
Primary human bone marrow mesenchymal stem cells (MSC) were used to

quantify cell attachment and proliferation on CHI-CaP scaffolds. Frozen cells of passage
1 from a 24 year old male donor were obtained from Texas A&M Health Science Center
College of Medicine Institute for Regenerative Medicine at Scott & White (Temple, TX).
Screening tests verified that these cells met the minimal criteria, which define human
mesenchymal stem cells as established by the Mesenchymal and Tissue Stem Cell
Committee of the International Society for Cellular Therapy. Cell vial was placed on ice
until everything was set. Cells were thawed and plated in a new sterile cell culture flask
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at approximately 5x103 cells/cm2. Cells were cultured in StemLife™ MSC Medium
(Lifeline Cell Technology, Frederick, MD). Cell medium was changed every 3-4 days.
Cells were subcultured before reaching confluence. Cells attached to the flask were
released by enzymatic treatment using trypsin. Trypsin was added to cover the bottom
layer of the flask and left in the incubator for 10 min for cell detachment from flask. Cell
culture medium with 10% FBS was added to stop the action of trypsin. All the cells and
medium were collected into a sterile 50 ml centrifuged at 500g for 5 min. The supernatant
was discarded and the cell pellet was resuspended into fresh cell culture medium and
plated again in new cell culture flasks at approximately 5x103 cells/cm2.
2.2.4

Biphasic constructs
MSCs at passage 4 were used for making biphasic constructs. After enzymatic

treatment with trypsin and centrifugation, the cells were resuspended at 5x105 cells/ml.
50 l of cell suspension was pipetted directly on top of each CHI-CaP scaffold. Few 50
l of cell suspension aliquots were frozen to determine the initial cell seeding number.
These constructs were left for 30 min in the incubator at 37°C with 5% CO2 allowing the
cells to attach to the scaffold. During this time the constructs were flooded with defined
chondrogenic medium (DCM). DCM consisted of high glucose Dulbecco’s Modified
Eagles Medium (DMEM) containing 1% ITS+Premix (BD Biosciences, San Jose, CA),
0.1 mM dexamethasone, 50 µg/mL ascorbate-2 phosphate, 1 mM sodium pyruvate, 40
µg/mL L-proline, 1% antibiotic-antimycotic solution (Sigma-Aldrich, St. Louis, MO),
and 10 ng/ml human recombinant transforming growth factor-β3 (PeproTech, Rock Hill,
NJ). These constructs were cultured for either 1 or 28 days in DCM. DCM was changed
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every 3-4 days. Day 1 cultures were used to assess cell attachment quantitatively by
measuring DNA (n = 3). Day 28 cultures were used to evaluate cell proliferation and
chondroinduction based on content of DNA and GAG, respectively (n = 6). One 24 hour
construct was also examined using SEM. Attachment efficiency (T1/2) was calculated
from Equation 2.2, where q1 was the average DNA content of cells in the aliquot used for
seeding, and q2 was the DNA content on the discs after 30 minutes of seeding.
𝑞

(2.3)

𝑇1 = ( 1 ) 100,
2

𝑞2

The rate of cell population doubling time (Td) was calculated from Equation 2.3,
where q1 and q2 were the average DNA content at 30 minutes (t1) seeding and DNA
content on the disc at 28-day (t2) time duration respectively.
𝑇𝑑 = (𝑡2 − 𝑡1 )

𝑙𝑜𝑔 2
𝑞

𝑙𝑜𝑔𝑞2

,

(2.4)

1

2.2.5

DNA and GAG quantification
Samples designated for biochemistry (DNA/GAG) were digested in 1% papain

overnight at 60°C. Samples were then centrifuged at 10,000 rpm for 3 min. One aliquot
of the digested sample was used for analyzing DNA content by Hoechst dye method in
DNA quantification kit (Sigma-Aldrich, St. Louis, MO). Fluorescence intensity was read
in Glomax Multi detection system. DNA content was calculated from a standard curve
produced with calf thymus DNA provided in the kit. By quantifying DNA we can
measure cell number and cell proliferation rate. Total DNA content will be normalized to
the sample wet weight. Another aliquot of the digested sample was used for GAG
quantification. Total GAG content was determined by the dimethylmethylene blue
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(DMMB) dye-binding method using the Blyscan™ Assay (Biocolor Ltd, Carrickfergus,
United Kingdom) according to the manufacturer’s instructions. The GAG content was
read at 656 nm in spectrophotometer. GAG content was calculated from a standard curve
produced with the chondroitin 4-sulfate standard provided in the kit. Total GAG amount
was normalized to the wet weight of the sample. GAG and DNA were analyzed in the
same way as mentioned in previous studies [13].
2.2.6

SEM sample preparation
The structure and the surface morphology of the constructs were examined using

Scanning Electron Microscope (SEM). Constructs for SEM were fixed in 2.5%
glutaraldehyde in PBS for overnight at 4°C. Later the scaffolds were dehydrated in
graded ethanol (30%, 50%, 70%, and 90%) for 20 min at room temperature. Scaffolds
were finally incubated in two changes of 100% ethanol and hexamethyldisilazane for 20
min each, and air dried under hood for about 30 min. These samples were then sputter
coated with platinum and imaged using a JEOL JSM-6500F Field Emission Scanning
Electron Microscope.
2.3
2.3.1

Results
Scaffold mechanical testing
Chitosan Calcium Phosphate scaffolds were fabricated as mentioned in

experimental design. Freeze dried CHI-CaP scaffolds were approximately 6mm in
diameter and 7 mm in height as shown in figure 2.7. Incubating the scaffolds in culture
medium for up to 28 days had no discernible effect on their compressive Young’s
modulus of approximately 5 MPa (Figure 2.8), which approaches the lower range of
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modulus for human trabecular bone [14]. None of the scaffolds broke during testing, but
they were deformed from their original shape (Figure 2.9).

Figure 2.7

Freeze dried cylindrical shaped scaffold of approximately 6 mm in
diameter and 7 mm in height.

45

Figure 2.8

Young’s modulus of scaffolds in unconfined compression

(n = 5)
Differences among groups were not statistically significant by one-way ANOVA (p >
0.05).

46

Figure 2.9

Scaffolds after mechanical testing

a) and b) are the top and side view images of the scaffold incubated for 24 h in DMEM,
c) and d) are the top and side view images of (a and b) after mechanical testing. The
scaffolds did not tear apart completely but they were deformed from their original shape.
2.3.2

Cell attachment and proliferation
Frozen P1 MSCs derived from the marrow of a 24 year old male were expanded

to P4 in monolayer. 2.5×104 cells were pipetted onto a flat surface of each scaffold and
allowed 30 min to attach before flooding with DCM. Seeding efficiency was expressed as
the percentage of cells attached to the scaffold relative to the total number, which were
seeded. The seeding or attachment efficiency of human bone marrow MSCs on CHI-CaP
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scaffolds was 37.5±7.5% (mean ± standard deviation) with 95% confidence interval after
30 minutes of cell seeding. Cells attached to the CHI-CaP scaffolds proliferated as
evidenced by almost 50-fold over the 4-week culture period. The cell proliferation rate
results to a population doubling time of 4.84±0.09 days with 95% confidence interval.
GAG was measured using dimethyl methylene blue assay and it was below the detection
limit.
After 24 hours of human bone marrow mesenchymal cell seeding, cells attained a
flattened and elongated or stellate morphology as shown in SEM images (Figure 2.10).
SEM images also showed that some cells reached and spread the gap between adjacent
CHI-CaP beads (Figure 2.11).

Figure 2.10

Scanning electron micrographs of human MSCs on top of a bead made up
of CHI-CaP after 24 h of cell seeding (200X).
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Figure 2.11

2.4

Scanning electron micrographs of human MSCs in the pore between the
beads made up of CHI-CaP after 24 h of cell seeding.

Discussion
Previous studies have already shown bilayered approach for cartilage tissue

engineering where one phase or layer is designed for bone formation (osteogenesis) while
other supports neocartilage formation (chondrogenesis) [15,16]. In a typical bilayered
approach either the scaffold is made up of two types of material or two cell types were
used to make biphasic constructs. In the current study the biphasic construct was made up
of only one type of material (CHI-CaP) and only mesenchymal stem cells were used to
form neocartilage through self-assembly, which was similar to Waldman et al. approach
for biphasic constructs [17].
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The osteoconductive scaffold is fabricated by fusing chitosan calcium phosphate
beads formed using co-precipitation method [6]. Chesnutt et al. also shown that the
calcium and phosphate was evenly distributed through the chitosan matrix in the
scaffolds fabricated using co-precipitation method. Porosity of the scaffolds was created
by fusing beads and was sufficient for tissue formation and nutrient transport. The size
and shape of the scaffold will be chosen depending on the defect size and it can be
managed by altering the size and shape of the mold in the custom plate. The compressive
modulus of the CHI-Cap scaffolds was in the lower range of the native trabecular bone
modulus and falls in the midpoint of the modulus of similar type scaffolds [6].
This study demonstrates that freeze-dried chitosan-CaP scaffolds support primary
human bone marrow MSC attachment and proliferation when cultured in DCM. The cells
attained a flat and spindle shape, fibroblast-like morphology within 24 h of cell seeding
as examined under SEM. The cell attachment or seeding efficiency of human
mesenchymal stem cells was approximately 38% and is similar to human embryonic
palatal mesenchymal cells on CHI-CaP scaffolds of similar composition [6]. In the
current study the DNA increased to 50-fold in 28 day whereas the DNA rose to 3-fold in
4 days (from Day 3 to Day 7) of human embryonic palatal mesenchymal cells.
When seeded at relatively low density, the primary human mesenchymal stem
cells attached and proliferated to cover the surface of the scaffolds, but the lack of any
GAG accumulation over 28 d suggests they did not undergo chondrogenic induction,
even in the presence of 10 ng/ml TGF-β3. The most likely explanation is the lack of
adequate cell-cell interaction or ability to acquire a round shape. Previous studies have
shown chondrogenic differentiation of MSCs when cultured in a pellet or embedded in a
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hydrogel [18,19] . Further investigations need to be done to create an ideal biphasic
construct with completely covered neocartilage tissue on it having chondrogenic
characteristics.
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TWO DIFFERENT APPROACHES FOR MAKING BIPHASIC CONSTRUCTS

3.1

Introduction
Scaffolds in tissue engineering play an important role in supporting cell

attachment and tissue regeneration. Hydroxyapatite (Ca10(PO4)6(OH)2) and chitosan are
widely used as scaffold materials in musculoskeletal tissue engineering applications.
Hydroxyapatite, a bone mineral salt is mainly composed of calcium and phosphate in
inorganic phase which constitute to approximately 70% of calcified bone. The main
advantages of using Hydroxyapatite is its bioactivity, osteoconductivity,
biocompatability, and biodegradation whereas shaping it is the major drawback due to
brittleness and easy to fracture nature [1,2,3]. Chitosan has weak mechanical properties
when used alone as a biomaterial. Combining chitosan and hydroxyapatite improves
hardness of the scaffold with load bearing capability makes an excellent osteoconductive
biomaterial [4]. Moreover studies have also shown that coating chistosan with nanohydroxyapatite improved cell proliferation on scaffolds [5,6]. Several methods have been
studied to incorporate chitosan and hydroxyapatite into one biomaterial. But, the coprecipitation method [7,8] stood out as it yielded a homogenous mixture whereas other
methods like mixing chitosan with hydroxyapatite/ calcium phosphate powders [9,10] or
coating chitosan with hydroxyapatite resulted in inhomogeneous solutions [11].
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Previous studies have shown various techniques for creating biphasic constructs
for cartilage tissue engineering using one or two biomaterials and cell types. In a study,
Hu Da et al. fabricated biphasic constructs using two different materials and two different
cell types for osteochondral defects [12]. Biphasic constructs were also created by
seeding one type of cells onto a biomaterial scaffold enclosed in a static bioreactor [13]
or using vacuum infusion technique [14]. Few studies have also reported biphasic
constructs formed by suspending cells in an agarose/alginate/silk hydrogels for cartilage
regeneration [15,16,17,18]. Kim et al. formed multilayer constructs having zonal
organization for articular cartilage defects by mixing chondrocytes from three different
zones with hydrogels separately and then combining the layers using
photopolymerization [19].
In our approach neocartilage (chondrogenesis) will be formed from MSCs by selfassembly on top of osteoconductive CHI-CaP scaffold (osteogenesis) [21]. In this study
biphasic constructs were created using two different approaches and evaluated based on
tissue formation, SEM, histology, immunohistochemistry, DNA and GAG results after 28
days culture in define chondrogenic medium (DCM).
3.2
3.2.1

Methods
Scaffold fabrication
Porous cylindrical shaped composite chitosan calcium phosphate scaffolds were

fabricated as described previously by Chesnutt et al. [21]. The current method differs
from Chesnutt et al. by using chitosan of 78.7% DDA, where they used 92% for scaffold
fabrication. In brief, the CHI-CaP beads were made using co-precipitation method.
These beads were left in the precipitate solution for 24 h for the formation of
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hydroxyapatite [22] and then in DI water until it reach neutral pH. Beads were dried
overnight and then fused into cylindrical shape (6mm diameter and 7 mm height) using
2% acetic acid and dried overnight. All the scaffolds were frozen at -20°C for 2 h and
freeze dried overnight. Previous study has shown that freeze drying the scaffolds will
increase pore size, porosity and protein absorption [23]. The scaffolds were then gas
sterilized using ethylene oxide before cell seeding.
3.2.2

Scaffold characterization
Freeze-dried scaffolds were weighed before and after rehydration in PBS for 24 h.

Swelling ratio was calculated as the percent increase in mass after rehydration. Porosity
was calculated as shown in Equation 3.1 where Δv is the volume of methanol displaced
by a scaffold and va is the apparent volume calculated from its measured diameter and
height [21]. microCT scanning was performed on one CHI-CaP scaffold to confirm that
the pores were interconnected.
𝑃 = (1 −

3.2.3

∆𝑣
𝑣𝑎

)

(3.1)

Cell source
Primary porcine bone marrow cells were used for creating biphasic constructs.

These cells were collected from four femurs of two pigs, which were bought from a local
meat processor. Bones were first cleaned and the entire process was done under aseptic
conditions. Bones were cut open and the marrow and fat from the diaphyseal region were
collected into a sterile centrifuge tubes. These tubes were centrifuged at 1000g for 10
minutes to separate marrow. Marrow was then distributed by continuous pipetting and it
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was transferred into a T-175 cell culture flask. Marrow was incubated in Dulbecco’s
Modified Eagle Medium (DMEM) containing 10% of fetal bovine serum at 37°C. After
24 h of incubation, the media was removed, flask was rinsed thoroughly with PBS to
remove any non-adherent cellular material and the cells were supplied with fresh DMEM.
Before reaching confluence, cells were treated with trypsin and subcultured into a new
flask. Cells at second passage were used for making biphasic constructs.
3.2.4

Biphasic constructs
In this experiment, biphasic constructs were created and compared using a higher

density of porcine bone marrow derived mesenchymal stem cells in two different
approaches (n=6 for each approach). For both the approaches scaffolds were fabricated in
the same way. In first approach cells were seeded on top of a scaffold resting in a
solidified agarose well and in second approach cells were placed in the middle of
solidified agarose and the scaffold was placed on cell suspension. These biphasic
constructs were cultured for 28 days in defined chondrogenic medium (DCM) and the
tissue formed was evaluated quantitatively by measuring DNA and GAG and
qualitatively by SEM and histological images.
3.2.4.1

Approach # 1
Wells of a 6 well plate were filled with 1.5% low gelling temperature agarose in

DMEM, leaving the scaffolds in the middle of the well. Once the agarose had solidified a
4 mm biopsy punch was used to cut a cylinder shaped hole above the scaffold (Figure
3.1). The overlying agarose was removed by pasteur pipette under vacuum.
Approximately 7.5x106 cells of second passage were pipetted onto each scaffold. The
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cells were allowed to settle for 60 min before the wells were flooded with DCM. Medium
was replaced every 4-5 days.
3.2.4.2

Approach # 2
2% low gelling temperature was poured in the wells of a 6 well plate holding

10mm stainless steel rods of the same diameter as the scaffolds. The rods were gently
removed after the agarose had gelled (Figure 3.1). The same number of cells as seeded in
approach # 1 were pipetted into each hole and allowed to settle for 30 min. Scaffolds
were then inserted into the holes and pressed gently against the cells. Later the wells were
flooded with DCM. Medium was replaced every 4-5 days.
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Figure 3.1

3.2.5

Schematic representation of crating biphasic constructs created using two
different approaches.

SEM sample preparation
The structure and the surface morphology of the constructs were examined using

scanning electron microscope (SEM). Constructs for SEM were fixed in 2.5%
glutaraldehyde in PBS for overnight at 4°C. Later the scaffolds were dehydrated in
graded ethanol (30%, 50%, 70%, and 90%) for 20 min at room temperature. Scaffolds
were finally incubated in two changes of 100% ethanol and hexamethyldisilazane for 20
min each, and air dried under hood for about 30 min. These samples were then sputter
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coated with platinum and imaged using a JEOL JSM-6500F Field Emission Scanning
Electron Microscope.
3.2.6

DNA and GAG quantification
Samples designated for biochemistry (DNA/GAG) were digested in 1% papain

overnight at 60°C. The samples were then centrifuged at 10,000 rpm for 3 min. One
aliquot of the digested sample was used for analyzing DNA content by Hoechst dye
method in DNA quantification kit (Sigma-Aldrich, St. Louis, MO). Fluorescence
intensity was read in Glomax Multi detection system. DNA content was calculated from a
standard curve produced with calf thymus DNA provided in the kit. Cell number and cell
proliferation rate were calculated from DNA readings. Another aliquot of the digested
sample was used for GAG quantification. Total GAG content was determined by the
dimethylmethylene blue (DMMB) dye-binding method using the Blyscan™ Assay
(Biocolor Ltd, Carrickfergus, United Kingdom) according to the manufacturer’s
instructions. The GAG content was read at 656 nm in spectrophotometer. GAG content
was calculated from a standard curve produced with the chondroitin 4-sulfate standard
provided in the kit. GAG and DNA were analyzed in the same way as mentioned in
previous studies [24].
3.2.7

Histology and Immunohistochemistry
Samples for histology were fixed in paraformaldehyde. Paraffin embedded

sections were sectioned along the diameter at 5 - 10 μm. All the sections were first
deparaffinized by rehydrating them in xylene and graded ethanol. The sections for
histology were stained with 2% toluidine blue for the detection of proteoglycans- rich
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extracellular matrix. Sections for immunohistochemistry were stained to detect type II
collagen. Immunohistological sections were incubated in 2mg/ml of hyaluronidase in trisbuffered saline for 30 minutes and then in 0.5mg/ml of pronase in PBS for 10 minutes for
antigen retrieval. Later the sections were incubated for 2 hours at room temperature in
full concentration II-II6B3 primary antibody from the Development Studies Hybridoma
Bank (University of Iowa, Iowa City, IA). The staining was then continued using
SuperPictureTM 3rd Gen IHC Detection Kit (Life Technologies, Grand Island, NY)
following the manufacturer’s recommended protocol. Sections without primary antibody
were used as controls. Control sections were incubated in PBS for 2 hours at room
temperature. These histology techniques were the same as those performed in previous
studies [24].
3.2.8

Degradation
In vivo, the CHI-CaP scaffold would be embedded in bone and would ideally

degrade at the same rate as new bone formation takes place. Lysozyme plays an
important role in chitosan degradation [25,26]. CHI-CaP beads made from chitosan with
a 78.7% DDA were incubated in a 1mg/ml lysozyme solution in PBS for up to 9 days.
The dried beads were weighed before incubating in lysozyme. After every 3 days the
beads were freeze dried for 2 days to remove any moisture and weighed. The lysozyme
solution was collected to perform calcium analysis, as these beads release calcium as they
degrade.
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3.2.9

Statistics
The quantitative data were analyzed by independent t-tests (α = 0.05) assuming

unequal variances. Analyses were carried out using IBM SPSS Statistics (19).
3.3
3.3.1

Results
Scaffold characterization
Cylindrical shaped scaffolds were fabricated by fusing CHI-CaP beads ranging

700-900 µm in diameter. The scaffolds made were approximately 47% porous (n=1),
which was measured using methanol displacement method and also the pores were
interconnected as evidenced in microCT images. The mass of the scaffold increased to
approximately 167% when rehydrated in PBS for 24 hours.
Table 3.1

Physical characteristics.

Increase in diameter

Increase in height

Swelling ratio (%)

with rehydration (%) with rehydration (%)
23.3±0.04

20.0±1.8

scaffold (%)
167.1±2.1

(n = 4, except for porosity n = 1)
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Porosity of dry

47.9

Figure 3.2

3.3.2

micro CT image of CHI-CaP beads fused into a cylindrical shaped scaffold
showing interconnected pores.

Biphasic constructs
Biphasic constructs created in two different approaches using porcine bone

marrow derived mesenchymal stem cells and CHI-CaP scaffolds were cultured for 28
days in DCM. There was no macroscopically visible neocartilage formation on top of
scaffolds formed using approach # 1. But, the SEM images of approach # 1 scaffold
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cultured for 28 days showed the beads of a scaffold were covered with a thin layer of
tissue mostly comprised of fibroblast like cells (Figure 3.3). Few isolated spherical
shaped cells resembling chondrocytes were observed at the gap between CHI- CaP beads
(Figure 3.4).

Figure 3.3

Scanning electron micrographs showing the presence of thin sheet of
porcine bone marrow mesenchymal stem cells on top of CHI-CaP beads
created using approach # 1 (85X).
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Figure 3.4

Scanning electron micrographs showing the presence of more chondrocyte
like cells in the deep crevices between the beads of composite CHI-CaP
scaffolds formed using approach # 1.

On the other side, the biphasic constructs formed using approach # 2 had a
macroscopically visible cartilage like tissue impression after 28 d culture in DCM (Figure
3.5). The cells were more round in shape and consisted of proteoglycans which was
evident in sections stained with toluidine blue (Figure 3.6). The tissue formed also
showed the presence of collagen type II, which was one of the main characteristics of
cartilage tissue (Figure 3.7). The main drawback of this approach would be the tissue
coverage. The neocartilage like tissue formed did not cover the whole seeded area. The
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approach # 2 constructs resulted in less DNA amount (or fewer cells) and has more GAG
compared to approach # 1 (Table 3.2).

Figure 3.5

Neo cartilage like tissue formed on composite CHI-CaP scaffolds

Tissue on constructs created using approach # 2 after culturing for 28 d in defined
chondrogenic medium using porcine bone marrow mesenchymal stem cells.
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Figure 3.6

Toluidine blue stained section of cartilage like tissue formed on composite
CHI-CaP

Tissue formed on constructs created using approach # 2 after culturing for 28 d in defined
chondrogenic medium using porcine bone marrow mesenchymal stem cells.
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Figure 3.7

Cartilage like tissue intensively stained for collagen type II, formed on
composite CHI-CaP scaffolds

Tissue formed on constructs created using approach # 2 after culturing for 28 d in defined
chondrogenic medium using porcine bone marrow mesenchymal stem cells.
Table 3.2

DNA and GAG content after 28 d culture of porcine bone marrow MSCs on
freeze-dried CHI-CaP scaffolds.
DNA (µg/construct)

GAG (µg/construct) GAG (µg)/ DNA (µg)

Approach #1

23.50±5.34

0.67±0.53

0.03±0.02

Approach #2

14.81±0.32

2.67±0.31

0.18±0.02

(mean ± standard deviation, n = 6)
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3.3.3

Degradation
Chitosan calcium phosphate beads degradation was studied by incubating them in

1mg/ml of lysozyme in PBS for 9 days. The rates of calcium release and weight loss were
shown in figure 3.8. There was no significant difference in the weight loss or calcium
release readings. This translates to a very slow rate of degradation in vivo.

Figure 3.8

Results from CHI-CaP bead degradation using lysozyme.

Total amount of calcium released is shown in (A) and (B) shows the percentage of weight
loss after incubating CHI-CaP beads in 1mg/ml of lysozyme solution in PS (n=1).
69

3.4

Discussion
It has been a main problem in securing the cartilaginous tissue formed in vitro and

placing it on top of a bone in vivo [20]. To overcome this we propose a new therapy
where neocartilage was formed on CHI-CaP scaffolds in vitro and the scaffold will be
replaced by new bone eventually in in vivo. The in vitro cultured cartilage was found to
fuse with the in vivo cartilage when they were in contact upon implantation [27]. It has
previously been demonstrated that engineered cartilage formed by self-assembly can
acquire an organized collagen architecture resembling that of native articular cartilage
[24]. CHI-CaP scaffolds fabricated have interconnected pores with 47% porous which
was little above the value presented by Chesnutt for similar type of scaffolds. Previous
studies show that a porosity of 30-40% is enough for nutrient transport and tissue
formation in vitro and in vivo [28,29]. The swelling ratio of these scaffolds was almost
same as that published by Chesnutt. Degradation of CHI-CaP beads was measured over
nine day time period by incubating beads in 1mg/ml lysozyme in PBS. There was no
significant change in the weight loss or the calcium released. The rate of degradation will
depend on several factors like – DDA, crystalline nature, and pore size [30,31].
In the current study biphasic constructs were created using two different
approaches where, either the cells were seeded directly on top of a scaffold or the
scaffold was gently pressed on cell suspension. The study showed that a thin layer of
cartilage tissue devoid of scaffold can be formed on top of a CHI-CaP scaffold when
seeded with large cell number. Biphasic constructs created using approach # 2 showed
the formation of neo cartilage like tissue with round shaped cells and more proteoglycan
and collagen type II. But, the tissue formed was not well adhered and did not cover the
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whole seeded area. None of the approach # 1 constructs consisted of macroscopically
visible tissue formation, but the SEM images showed that the scaffold was covered with a
thin layer of tissue with more chondrocyte-like cells clearly seen in the junction between
the beads. Approach # 2 constructs had low GAG readings compared to approach # 1
measured on scaffold. The histology sections of the tissue formed using approach #2
showed the presence of abundant proteoglycan and type II collagen with more spherical
shaped cells. Presence of more proteoglycan, type II collagen and spherical shaped cells
were the characteristic feature of articular cartilage tissue. These histology images
showed that mesenchymal stem cells were differentiated into chondrocytes when
supplied with TGF-β3.
The main advantage of approach # 1 is that the cells are in close contact with the
medium for nutrient and waste transport. But the drawback is that the cells did not stay in
the initial cell seeded area. They migrated through the pores of the scaffold as it expands
upon rehydration in culture medium. Maintaining the porosity below 40% may help to
overcome this issue. For approach # 2, the cells were confined to the initial cell seeded
area, which also helps for cartilaginous extracellular matrix organization. But the cells
were not in contact with the medium for nutrients.
The main limitations for both the approaches are cell adhesion and formation of
continuous cartilage tissue on scaffolds. A preliminary study has shown that cell adhesion
can be increased when scaffolds were coated with a protein. Scaffolds coated with 0.05%
collagen and 0.02% fibronectin were created and compared against non-coated scaffolds
(Figure 3.9). Same number of cells was seeded for all the groups and biphasic constructs
were created using approach # 1. From these results we propose that coating scaffolds
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with a protein and creating biphasic constructs using approach # 1 will be an ideal
method for articular cartilage regeneration.

Figure 3.9

Dried biphasic constructs created using approach # 1, showing the presence
of tissue covered

Top row – tissue on uncoated CHI-CaP scaffolds, Middle row – tissue on collagen coated
scaffolds, Last row – tissue on fibronectin coated scaffolds.
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MESENCHYMAL STEM CELL MEDIATED CHONDROGENESIS ON CHITOSAN CALCIUM PHOSPHATE SCAFFOLDS: EFFECT OF COLLAGEN COATING

4.1

Introduction
As previously mentioned, there is a need for an alternative approaches to articular

cartilage repair. Our approach to cartilage tissue engineering is a biphasic construct, in
which one layer supports to form subchondral bone (osteogenesis) and another supports
cartilage formation (chondrogenesis) [1,2]. The goal is to create a tissue engineered
biphasic osteochondral plug by seeding human bone marrow mesenchymal stem cells
(hbMSCs) (chondrogenic layer) on top of a porous chitosan-calcium phosphate (CHICaP) scaffold (osteogenic layer). The scaffold provides a 3D environment and structure
for the delivery of cells, and it must have similar interconnected porosity as that of bone
to support not only the ingrowth of tissue but also the nutrient transportation to cells and
removal of waste products. However, the scaffold must be strong enough to provide
support to the defect site until the formation of new bone.
The scaffold currently under investigation in our laboratory is made from
chitosan, a deacetylated derivative of chitin found in the exoskeleton of marine
crustaceans. Chitosan has a wide range of biomedical applications. Previous research
revealed that chitosan has hemostatic and cholesterol lowering properties [3]. Chitosan is
a biocompatible and osteoconductive polymer with enhanced wound-healing capability
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[4,5]. Also, antimicrobial properties of chitosan could reduce bacterial infection upon
implantation [6,7]. Combining chitosan with calcium phosphate, a calcium salt found in
the inorganic phase of bone mainly as hydroxyapatite, improves osteoconductivity,
strength, and rigidity of the scaffold [8]. CHI-CaP scaffolds can be fabricated with at
least 35% porosity, which is sufficient to support new tissue ingrowth. Our aim is to
create a biphasic construct by high density seeding of hbMSCs onto a CHI-CaP scaffold.
Previous investigations done by Chesnutt et al. have shown that CHI-CaP
scaffolds support cell attachment and proliferation of human fetal osteoblast cells and
human embryonic palatal mesenchymal cells [9,10]. From our previous study, we have
also shown that hbMSCs and porcine mesenchymal stem cells can attach and proliferate
on CHI-CaP scaffolds [11], but weak attachment led to poor cartilage tissue integration
and minimal coverage of the scaffold surface. Previous studies have shown an increase
in cell attachment and viability when scaffolds are coated with extracellular matrix
protein [12], and we hypothesized that the CHI-CaP scaffold would similarly benefit
from such a coating. A pilot experiment suggested type I collagen coating could
effectively enhance cell adhesion. Collagen type I provides a structural framework for
connective tissue and helps in the formation of new bone [13]. Previous studies have
shown that enhanced mesenchymal stem cell adhesion and survival on collagen
enhancement was mediated by transmembrane integrins [14].
The main purposes of this study were to determine what effects coating the CHICaP scaffold with type I collagen would have on hbMSCs cell adhesion and
chondrogenesis and how it would affect the physical characteristics of the scaffolds. It
was hypothesized that collagen coating would promote cell attachment and
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chondrogenesis on CHI-CaP scaffolds with minimal alteration of the scaffold’s physical
properties. To test this hypothesis, coated and uncoated scaffolds were characterized
based on microscopic appearance, porosity, swelling ratio, and
hydrophobicity/hydrophilicity. In addition, coated and uncoated scaffolds were seeded
with hbMSCs and analyzed for cell proliferation and chondrogenesis.
4.2
4.2.1

Methods
Fabrication of composite chitosan calcium phosphate scaffolds
Composite CHI-CaP beads were prepared by a co-precipitation method as

described previously [9]. In short, these were made by dissolving 3.57gm of 78.7%
degree of deacetylation (DDA) chitosan powder (Vanson Halosource, Redmond, WA) in
84ml of 2 wt% acetic acid having CaCl2 and NaH2PO4 to make a final Ca:P ratio of 1.67.
Using a syringe pump and an 18G needle, the chitosan solution was added drop wise into
a magnetically stirred precipitate bath at 15ml per hour. The precipitating solution
consisted of 20% NaOH, 30% methanol, and 50% DI water (pH 13). These drops
precipitated into beads. The beads were left in the precipitate solution for 24 hours for the
formation of crystalline hydroxyapatite. The precipitating solution was replaced by DI
water regularly until it reached pH 7. The beads were then separated and air dried
overnight. The dried beads were packed into cylindrical molds and fused into scaffolds
by brief exposure to 1% acetic acid and manually applied pressure. The scaffolds were
extensively washed with DI water to remove any traces of acetic acid and air dried
overnight. They were then washed in 70% ethanol for 2 hours at room temperature and
the residual ethanol was washed out using DI water. Scaffolds were then frozen at -20°C
for 3 hours and lyophilized overnight to enhance porosity, surface texture, and protein
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adsorption [8]. The scaffold fabrication technique in the current study is distinguished
from Chesnutt et al, as we incorporated lyophilization. The scaffolds to be coated were
soaked in 0.05% type I collagen from rat tail (Sigma, St. Louis, MO) in phosphatebuffered saline (PBS) for 3 hours at room temperature and air dried overnight. All the
scaffolds were EtO gas sterilized before use. The resulting scaffolds were approximately
6 mm in diameter and 7 mm in height.
4.2.2

Scanning Electron Microscopy
The surface morphology of composite CHI-CaP scaffolds was examined under

the scanning electron microscopy (SEM). The scaffolds designated for SEM were fixed
in 2.5% glutaraldehyde in PBS, dehydrated in graded ethanol and hexamethyldisilazane,
and air dried. These scaffolds were then sputter coated with platinum and imaged on a
JEOL JSM-6500F Field Emission Scanning Electron Microscope.
4.2.3

Porosity and Swelling ratio
Freeze dried scaffolds were weighed and dimensions were measured using digital

calipers. Porosity was determined by volume displacement using methanol as described
previously [9]. Three scaffolds of known dimensions were taken into a tube having 300µl
of methanol. Porosity was calculated from Equation 4.1, where Δv is the volume of
methanol displaced by scaffolds and va is the apparent volume calculated from the
diameter and height of the scaffolds. The scaffolds were weighed, and dimensions were
measured again after rehydrating them in PBS for 24 hours at 37°C. The porosity of
hydrated scaffolds was measured similarly, by volume displacement of water. Starting
volume of water was 800µl water. In Equation 4.1, Δv was the volume of water
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displaced by hydrated scaffolds and va was the apparent volume calculated from the
diameter and the height of the hydrated scaffolds. The swelling ratio was calculated as
the percentage increase in weight upon rehydration. The porosity and the swelling ratio of
collagen coated scaffolds were compared against uncoated scaffolds.
P = (1 – Δv/va)
4.2.4

(4.1)

Contact angle
To eliminate the effect of surface irregularity, contact angle measurements were

made on solid collagen-coated and uncoated CHI-CaP discs having a final diameter of
approximately 7 mm. Solid CHI-CaP discs were identical in composition to the porous
scaffolds. Discs were made by filling wells of a 6-well polystyrene culture plate with
chitosan solution and overlaying the precipitating solution for 24 hours. The precipitating
solution was replaced by DI water until a neutral pH was reached. Discs were removed
from the plate and placed into a custom press, which prevented them from warping
during lyophilization. Half of the total number of discs were coated with 0.05% type I
collagen in the same manner as porous scaffolds were coated. A 15µl drop of water was
pipetted onto the center of the disc, and a digital photograph was captured within 7-10
seconds after pipetting. The image was processed using drop analysis LB-ADSA plugin
of ImageJ software [15].
4.2.5

Human mesenchymal stem cell culture
Biphasic constructs were prepared using primary human bone marrow

mesenchymal stem cells. Frozen passage 1 hbMSCs from a 22-year old healthy male
donor were obtained from the Texas A&M Health Science Center College of Medicine
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Institute for Regenerative Medicine at Scott & White (Temple, TX). The cells met the
minimal criteria which define mesenchymal stem cells as established by the
Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular
Therapy [16]. The cells were thawed and plated at approximately 5-6×103 cells/cm2.
They were expanded in Dulbecco’s modified Eagle Medium (DMEM) (Sigma, St. Louis,
MO) containing 5% Fetal Bovine Serum, 1% Mesenchymal Stem Cell Growth
Supplement (ScienCell Research Laboratories, Carlsbad, CA), and 1% antibioticantimycotic solution (Sigma, St. Louis, MO). The cells were subcultured using trypsin
before reaching confluence.
4.2.6

Cell attachment and proliferation
To avoid inadvertent loss of any part of the inoculating cell suspension and to

control for variability in scaffold architecture, cell attachment and proliferation rate
studies were conducted using non-porous solid discs. HbMSCs were seeded onto circular
flat CHI-CaP discs of approximately 20mm in diameter which were fabricated as
described for contact angle measurements. Collagen coating and sterilization were
performed in the same way as for porous scaffolds. Third passage hbMSCs were
resuspended at 1×105 cells/ml in defined chondrogenic medium (DCM), and 0.5ml of cell
suspension was pipetted onto the central region of each disc. Additional 0.5ml aliquots
were frozen to establish the DNA content of the seeded cells. DCM consisted of high
glucose DMEM containing 1% ITS+Premix (BD Biosciences, San Jose, CA), 0.1 mM
dexamethasone, 50 µg/mL ascorbate-2 phosphate, 1 mM sodium pyruvate, 40 µg/mL Lproline, 1% antibiotic-antimycotic solution (Sigma-Aldrich, St. Louis, MO), and 10
ng/ml human recombinant transforming growth factor-β3 (PeproTech, Rock Hill, NJ)
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[17,18]. At 60 minutes and 7 days following cell seeding non-adherent cells were
removed by gentle rinsing with PBS, and attached cells were recovered by trypsinizing.
Frozen aliquots were lysed and DNA was quantified similar to that of the trypsinized
cells. DNA was quantified using the Hoechst assay to determine attachment efficiency
and proliferation rate, respectively. In addition, viability staining using the PromoKine
Live/Dead Cell Staining Kit II (PromoCell GmbH, Heidelberg, Germany) was performed
on one disc from each group after a time period of 3 days. Attachment efficiency (T1/2)
was calculated from Equation 4.2, where q1 was the average DNA content of cells in the
aliquot used for seeding, and q2 was the DNA content on the discs after 60 minutes of
seeding.
𝑞

(4.2)

𝑇1 = ( 1 ) 100
2

𝑞2

The rate of cell population doubling time (Td) was calculated from Equation 4.3,
where q1 and q2 were the average DNA content at 60 minutes seeding and DNA content
on the disc at 7-day time duration respectively.
𝑇𝑑 = (𝑡2 − 𝑡1 )

𝑙𝑜𝑔 2
𝑞

𝑙𝑜𝑔𝑞2

,

(4.3)

1

4.2.7

Creation and Evaluation of Biphasic Osteochondral Constructs
To investigate chondrogenesis in vitro, porous coated and uncoated scaffolds

were first embedded in 1.5% agarose in a 6-well plate. Thus the scaffolds were buried
underneath a layer of agarose approximately 4 mm thick. A biopsy punch was used to
make a 4mm diameter cylindrical cut through the agarose overlying the scaffold. The
agarose in that region was removed by Pasteur pipette under vacuum, thereby exposing
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an area for cell seeding. A pilot study was performed to observe tissue formation and to
measure the effect of coating on cell proliferation. A 50 μl aliquot of cell suspension
containing approximately 4×106 passage 6 hbMSCs was pipetted on top of each scaffold,
and the cells were permitted 4 hours for self-assembly before any additional medium was
added. These constructs were cultured for 21 days in DCM, at which time they were
digested for 12 h at 60 °C in 100 mM Na2HPO4, 10 mM Na2EDTA, 10 mM L-cysteine,
and 0.125 mg/mL papain. DNA in the supernatant was precipitated using 3M sodium
acetate and 100% ethanol, resuspended in water, and quantified by measuring the optical
absorbance at 285nm on a Nanodrop 2000c spectrophotometer (Thermo Fisher Scientific
Inc., Waltham, MA).
Constructs to be used for evaluation of chondrogenesis were created in the same
way using fourth passage hbMSCs. These constructs were cultured for 28 days in DCM,
and the medium was changed every 2-3 days. The cells produced an opaque layer of
tissue which as easily distinguished in digital photographs. ImageJ software was used to
measure the projected surface area of the engineered tissue after manually outlining its
perimeter. The cultured constructs were also processed for histology and
immunohistochemistry. Formalin-fixed, paraffin-embedded and plastic-embedded
sections of all the constructs were stained with toluidine blue for proteoglycan detection
(2% toluidine blue in 1% glacial acetic acid) and with picro-sirius red to stain collagen
(0.1% Sirius red in a saturated aqueous solution of picric acid). Picro-sirius red-stained
sections were imaged under cross polarization, which reveals strongly oriented collagen
fibers as birefringent. At evenly spaced sites across each of 3 sections from 3 different
coated constructs, the angle of preferential collagen fiber alignment was measured in the
83

upper 20% and lower 30% (adjacent to scaffold) of the tissue using the OrientationJ
plugin to ImageJ [19]. Sections of coated constructs were not amenable to measurements
of collagen fiber alignment. Additional sections of collagen-coated and uncoated
constructs were immunostained for type II collagen. Antigen retrieval was performed by
incubating sections for 30 min at 100 °C in 10 mM sodium citrate buffer pH 6.0,
followed by incubation for 10 min at 37 °C in 0.5 mg/ml pronase in PBS. The collagen
epitope was exposed by incubating for 30 min at 37 °C in 2 mg/ml hyaluronidase in trisbuffered saline. Sections were incubated in a monoclonal anti-type II collagen primary
antibody overnight at 4° C (undiluted culture supernatant) (II-II6B3, Development
Studies Hybridoma Bank, University of Iowa, Iowa City, IA). The Superpicture 3rd
Generation IHC Detection Kit (Invitrogen, Carlsbad, CA) was then used according to the
manufacturer’s instructions.
4.2.8

Statistics
The quantitative data were analyzed by an independent t-test at α=0.05, and p-

values < 0.05 were considered statistically significant (IBM SPSS Statistics 19).
4.3
4.3.1

Results
Scaffold Characterization
The surface morphology of platinum sputter coated CHI-CaP scaffolds, collagen

coated and uncoated, were examined under SEM. SEM images showed a slightly bumpy
surface with nanoscale features, which was not affected by collagen coating (Figure 4.1).
There was no significant difference in physical properties between the collagen coated
and uncoated scaffolds (Table 4.1), with the exception of contact angle (Figure 4.2). The
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porosity of the dry collagen coated scaffold (36.06±3.62) was similar to that of the dry
uncoated scaffold (38.73±1.84), which was measured using methanol volume
displacement method. The porosity of the hydrated collagen coated scaffold (75.67±8.97)
was similar to the hydrated uncoated scaffold (69.01±6.55), which was measured using
water volume displacement. The swelling ratio, which was calculated as the increase in
mass upon rehydration, was also similar in both the groups (Table 4.1). Water contact
angle was significantly influenced by collagen coating. The contact angle on uncoated
CHI-CaP was 107.81°±13.09°, and on collagen coated discs it was 78.2°±8.71° (p<0.05).

Figure 4.1

Scanning Electron micrograph of freeze dried collagen coated and uncoated
composite CHI-CaP scaffold showing a slightly bumpy surface at 15000X
magnification.
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Table 4.1

Physical characteristics of collagen coated and uncoated scaffolds.

Characteristic

Collagen Coated
Scaffolds

Uncoated
Scaffolds

Porosity of dry scaffold (%) (n=5)

36.06±3.62

38.73±1.84

Porosity of hydrated scaffold (%) (n=5)

75.67±8.97

69.01±6.55

Swelling ratio (%) (n=5)

75.65±0.79

77.01±1.59

Increase in diameter after hydrating (%) 19.40±1.07
(n=5)

20.38±1.58

Increase in height after hydrating (%) (n=5) 20.79±1.42

20.12±0.58

Increase in volume after hydrating (%) 72.23±3.90
(n=5)

74.17±5.22

(values=mean±stdev)

Figure 4.2

Contact angle measurement on colalgen coated and uncoated CHI-CaP
discs.

Image caputered within 7-10 seconds after dropping 15 µl of water on a collagen coated
and an uncoated CHI-CaP disc for contact angle measurement using ImageJ.
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4.3.2

Cell attachment and proliferation
Composite CHI-CaP discs supported the attachment and the proliferation of

hbMSCs. More cells were attached to the collagen coated discs than to the uncoated ones.
The attachment efficiency for collagen-coated scaffolds was 70.88%±4.75% and for the
uncoated scaffolds was 51.07%±4.04% after 60 min of cell seeding (p<0.05) (Figure 4.3).
Cells in both groups proliferated as evidenced by 3-fold increases in recovered DNA
between 60 min and 7 days. However, there was no difference in population doubling
time (p=0.422), indicating equivalent rates of proliferation. More DNA, indicating a
greater number of cells, was recovered from collagen coated constructs on Day 7 than
from uncoated scaffolds (p<0.05). Many green fluorescent (live) cells, but no red
fluorescent (dead) cells were observed on the coated and uncoated discs on Day 3 (Figure
4.4).

Figure 4.3

The bar graph shows the amount of DNA on collagen coated and uncoated
scaffolds at 1 hour and 7 day time interval.

(*indicates both the groups are statistically different, p<0.05).
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Figure 4.4

Live dead staining of hbMSCs on CHI-CaP discs

Live dead staining of hbMSCs seeded at 1×105 cells/ml density on a collagen coated and
an uncoated composite CHI-CaP disc after 3 day time period (10X objective).
4.3.3

Biphasic constructs- DNA quantification
On Day 21, the cells had formed semi-translucent to opaque patches of tissue, the

sizes of which were much smaller on the uncoated scaffolds than on the collagen-coated
ones. There was somewhat more DNA in biphasic constructs made from collagen-coated
scaffolds than from uncoated scaffolds (2.04±0.44, and was 1.54±0.69 µg per construct,
respectively). However, due the relatively small sample size, a statistically significant
difference was not demonstrated.
4.3.4

Chondrogenesis
By Day 28, hbMSCs seeded on top of CHI-CaP scaffolds had synthesized a tissue

similar in to hyaline cartilage. The tissue on uncoated scaffolds was contracted into a
spherical mass which was easily dislodged. It covered a small fraction of the initial
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seeding area. On the other hand, the tissue on the coated scaffolds was a circular patch of
approximately uniform thickness. It appeared to cover the entire area onto which cells
had been seeded (Figure 4.5). Tissue area covered on collagen coated scaffolds was
11.09±2.25 mm2 and it was only 2.76±0.38 mm2 for uncoated scaffolds. As shown in
figure 5, the average projected surface area of tissue was 75% greater in the collagencoated group compared to the uncoated group (p<0.05).

Figure 4.5

Area of neocartilage formed on collagen coated and uncoated composite
CHI-CaP scaffolds.

Cartilage like tissue formed was extended into the pores on a collagen coated scaffold
while the tissue contracted into a spherical mass on uncoated scaffold. Area of the tissue
covered was statistically different between two groups, p<0.05.
4.3.5

Histology
In most of the uncoated constructs, the tissue detached from the scaffold during

the embedding process because it was not well adhered to the scaffold. On coated
scaffolds, but not uncoated ones, the tissue extended into the pores so that the tissue
contour matched the scaffold contour at their interface. The tissue on collagen coated
and uncoated scaffolds demonstrated strong metachromatic toluidine blue staining,
especially in the deep zone (Figure 4.6). Tissue formed on the control scaffolds did not
cover sufficient surface area for collagen orientation analysis. On collagen-coated
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scaffolds, the directions of preferential fiber alignment in the superficial and deep zones
were significantly different (0.30° vs. 95.5° with respect to the top surface, p<0.05), a
pattern which is similar to that observed in native articular cartilage (Figure 4.7). Positive
staining for type II collagen (brown color) was far more intense in the tissue grown on
collagen coated CHI-CaP than on the uncoated scaffolds (Figure 4.6), indicating a much
greater proportion of type II collagen in the extracellular matrix.

Figure 4.6

Toluidine blue and collagen type II staining on the neocartilage formed on
collagen coated and uncoated CHI-CaP scaffolds.

Histological sections of engineered cartilage formed on CHI-CaP scaffolds stained with toluidine
blue showed a strong metachromatic staining at deep zones, a circular patch of tissue extended
into pores on collagen coated scaffold and tissue contracted into a spherical mass on uncoated
scaffold. Immunohistochemistry sections, positive staining for type II collagen was intense in the
tissue grown on collagen coated CHI-CaP than the uncoated scaffolds at 10X magnification.
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Figure 4.7

Picosirius red stained neocartilage on collagen coated scaffolds.

Digitally isolated engineered cartilage on collagen coated scaffold stained for a)
picosirius red showing collagen fiber orientation in the superficial and deep zones b)
polarized light microscopy images showing birefringent collagen fibers alignment on
collagen coated scaffold.
4.4

Discussion
The current investigation advances a biphasic approach to cartilage tissue

engineering, in which one layer is designed to support osteogenesis (bone growth), and
another promotes chondrogenesis (cartilage regeneration). The osteoconductive phase is a
porous CHI-CaP scaffold. An extremely high density suspension of MSCs is layered on
top of the scaffold so that it will form a cartilaginous phase through self-assembly. It is
similar to the system previously described by Waldman et al., which involved the seeding
of articular chondrocytes onto a porous calcium polyphosphate substrate [20]. Our
approach is distinguished by use of a less brittle scaffold and by the use of MSCs. This
scheme is different from most other bilayered designs, which typically involve the fusion
of two different scaffold materials and/or incorporation of different cell types
[21,22,23,24].
Based on previous studies, chitosan has been regarded as a promising biopolymer
in tissue engineering. The main reason for choosing chitosan as a scaffold is its chemical
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similarity and its ability to interact with glycosaminoglycans of cartilage. Properties of
chitosan scaffolds, such as crystallinity, mechanical strength, and degradation, can be
varied by altering molecular weight and the degree of deacetylation [3]. Composite CHICaP scaffolds were found to have a significantly greater compressive modulus than
scaffolds of pure chitosan [9]. Furthermore, the modulus is approximately 10 MPa,
which is at the lower end of the range for human cancellous bone [25], and should be
sufficient for the initial transmission of joint forces to the underlying bone. In a study
done by Chesnutt et al., CHI-CaP scaffolds with DDA 92.3% seeded with human fetal
osteoblast cells were implanted in rat calvarial defect. After 12 weeks of study, the
histology images revealed the formation of new bone, but the chitosan scaffold had
undergone little degradation. In the current study, the scaffolds were fabricated using
chitosan of 78.7% DDA, which is expected to degrade faster [10]. Ideally, the rate of
scaffold degradation would match the rate of new bone formation.
In this study human bone marrow MSCs were used to generate the chondrogenic
layer of the biphasic scaffold. Autologous chondrocytes and MSCs are the most
commonly used cell sources for cartilage tissue engineering. Chondrocytes have limited
potential for expansion in vitro, and proliferation in monolayer results in cell dedifferentiation and declining chondrogenic potential [26,27]. On the other hand, use of
MSCs preserves all healthy cartilage in the affected joint and spares it from additional
trauma. MSCs are hypoimmunogenic, self-renewable, and can also proliferate for long
periods [10]. They also exhibit anti-apoptotic and wound healing properties [13]. We
have previously demonstrated that MSCs can be chondroinduced with high efficiency
when exposed to either TGF-β1 or TGF-β3 [17].
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Our previous study revealed that inefficient cell attachment to porous CHI-CaP
scaffolds was a hindrance to formation of a functional cartilage layer [11]. It was
hypothesized that coating the scaffolds with type I collagen would significantly improve
MSC adhesion. Collagen is roughly a third of the total body protein, and is abundant in
cartilage, bone, blood vessels, skin and many other tissues. It has both mechanical and
physiological functions. Mechanically it is excellent at resisting tensile loads, and
physiologically it supports cell attachment. Collagen type I was of particular interest. It
is the predominant type of collagen in bone, and the attachment of MSCs to collagen type
I is mediated by α1β2, α2β1, and α11β1 integrin receptors [28]. It has specifically been
shown to be superior to chitosan for enhancing cell attachment to PLGA scaffolds [29].
In a monolayer culture model, MSC attachment and proliferation on collagen type I was
compared to fibronectin, laminin I, and poly-L-lysine. MSCs adhered to collagen type I
with very high efficiency within 45 minutes, and collagen supported the highest rate of
cell proliferation [14]. Furthermore, collagen type I and type II coatings were found to be
equivalent in terms of promoting cartilaginous extracellular matrix production by human
articular chondrocytes [30].
This study demonstrated that coating the CHI-CaP scaffolds with collagen type I
serves to make them hydrophilic but does not otherwise alter their physical properties
including porosity, swelling ratio, and dimensional changes upon rehydration. The
porosity of these CHI-CaP scaffolds measured by methanol displacement method was
approximately 35%, irrespective of coating, and was similar to the porosity of chitosan
scaffolds fabricated by Chesnutt et al [10]. Although a greater void fraction is likely to
be advantageous, it is expected that this porosity is sufficient to support bone ingrowth
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[31]. Interconnectivity of the porous structure has been directly observed under microCT
scanning (data not shown). MSC adhesion was greater to the discs coated with collagen,
and proliferation was similar on collagen-coated and uncoated discs. Efficiency of
attachment to uncoated CHI-CaP was similar to that observed by Chesnutt et al. on
composite scaffolds [19], but lower than previously reported for collagen-coated tissue
culture plastic [14]. The improved adhesion is attributed to better scaffold wettability and
also to the abundance of ligands for MSC integrin receptors. Surface topography was
likely not a factor, as the surfaces of coated and uncoated scaffolds displayed similar
nanoscale features upon examination by SEM.
In this study, fourth passage human bone marrow MSCs was seeded directly on
top of a composite CHI-CaP scaffold within a circular agarose mold. After 4 weeks of
culture in defined chondrogenic medium containing TGF-β3, the cells had formed a firm,
white tissue resembling hyaline cartilage on top of collagen-coated and uncoated
scaffolds. The tissue formed on coated scaffolds was a layer of approximately uniform
thickness tightly adhered to the surface and covering the entire area of cell seeding. In
contrast, tissue formed on uncoated scaffolds was concentrated in a spherical mass which
occupied a small portion of the initial cell seeding area and which had a fragile
attachment to the scaffold. Contraction of the cell mass started approximately 48 h after
cell seeding. At the end of the culture period, the tissue on coated scaffolds covered 5
times as much surface area as the tissue on uncoated scaffolds. Complete coverage of
neotissue over the entire cell seeding area is essential for eventual application of this
approach to cartilage repair.
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Histology showed that the tissue on coated scaffolds conformed to the scaffold’s
shape, thereby covering a larger surface area than the projected area measured from
macroscale photograhs. On coated scaffolds, the tissue was approximately 400-500 µm
thick over the entire area of cell seeding. It displayed noticeably more metachromatic
staining with toluidine blue compared to tissue on uncoated scaffolds, which suggests a
higher proteoglycan concentration. It also stained intensely for collagen type II, in
contrast to the faint staining exhibited by the tissue on uncoated scaffolds. These
findings indicate that the collagen coating not only promoted cell adhesion, but
chondrogenesis as well. In fact, the tissue that formed on the collagen-coated scaffolds
displayed a distinct pattern of collagen fiber orientation. In a very narrow zone at the
upper surface, it was parallel to the upper surface. In a relatively wide zone adjacent to
the scaffold, it was roughly perpendicular to the upper surface. These zones were
separated by a zone of indistinct orientation. This pattern of alignment is very similar to
that found in articular cartilage with its superficial, transition, and deep zones containing
collagen that is aligned parallel, randomly, and perpendicular to the joint surface,
respectively. It is also the same pattern we previously observed in tissue engineered
cartilage formed by self-assembly of MSCs [17]. With respect to chondrogenesis, our
results are consistent with those of Ragetly et al., who demonstrated that coating chitosan
fibrous scaffolds with type II collagen increased MSC seeding efficiency, cartilaginous
extracellular matrix production, and surface area covered by extracellular matrix [12].
Thus coating with collagen may be generally beneficial to cartilage tissue engineering
approaches involving chitosan-based scaffolds.
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Our results clearly demonstrate that the collagen coating improves MSC adhesion
and promotes formation of a continuous cartilage layer on the scaffold’s surface.
However, the effect of collagen coating solution concentration was not investigated. The
0.05% concentration used in this study was considerably lower than the concentrations
used in a previous study to coat chitosan fibrous scaffolds, but that study found little
benefit to raising the concentration from 0.2% to 0.4%. Therefore we speculate that
collagen concentration-dependent effects on cell adhesion and chondrogensis may be
observed in our model within the range of 0.05% to 0.2%. Another limitation of the
current study was the inability to quantify the tissue-scaffold adhesive strength. Tissue
maturation, in terms of stiffness and thickness, was not adequate for mechanical testing.
Future studies will aim not only to optimize concentration of the collagen coating
solution but also the size of the beads from which scaffolds are created. Bead size affects
porosity, pore size, and surface morphology and is therefore predicted to strongly
influence tissue coverage and strength of adhesion to the scaffold.
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EFFECT OF BEAD SIZE ON SCAFFOLD CHARACTERISTICS

5.1

Introduction
Several studies have investigated engineering cartilage tissue using various

scaffold materials [1,2]. The scaffold material and architecture plays an important role in
tissue engineering. Scaffolds need to be fabricated in such a way that supports cell
proliferation, tissue formation, and nutrient and waste material transportation [3]. It acts
as an interim substitute and provides mechanical strength until new tissue formation takes
place. Pore size plays a major role in scaffold designing and it controls several factors
like tissue growth, mechanical integrity, degradation, nutrient, and waste material
diffusion [3,4,5]. Various methods have been discussed for creating porous scaffolds –
freeze drying [6], gas foaming [7], 3D printing [8], electrospinning [9], and phase
separation [10]. However, the perfect tissue engineered graft should possess almost same
structure and perform similar functions of a native tissue [11].
The scaffold material we are interested in is chitosan, a biocompatible,
biodegradable, and osteoconductive polymer with wound healing and antimicrobial
properties [12,13,14]. Chitosan along with calcium and phosphate was known to increase
the mechanical integrity of the scaffolds [15]. Previous studies have shown the potential
use of chitosan as a scaffold material for cartilage tissue engineering [16,17,18]. Chitosan
is also known to support cell attachment for various cell types [15,16,19] and cell
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attachment increased when coated with an extracellular matrix protein [20]. Chesnutt et
al. fabricated chitosan calcium phosphate scaffolds by fusing individual beads with
approximately 35% porous having 100-800 µm pore sizes [15]. By varying the bead size,
the pore size and porosity also varies, which reflects the design and architecture of the
scaffolds. A previous study has shown that freeze-drying of similar type of scaffolds
increased porosity and pore size [6].
Articular cartilage defects are classified into two types – chondral and
osteochondral defects. In chondral defects, the cartilage damage is limited to the cartilage
tissue; whereas in osteochondral defects, subchondral bone lying below the cartilage
defect also gets damaged. Several studies have shown the use of biphasic constructs for
treating osteochondral defects, where one phase represents bone and other cartilage. In a
traditional biphasic constructs, either two types of scaffold materials were fused together
[21,22,23] or two types of cells were seeded on top and bottom halves of the scaffold
[11,21,24]. In the current study, we are developing a tissue-engineered approach for
treating osteochondral defects using one biomaterial, chitosan calcium phosphate
scaffolds (CHI-CaP) and two different cell types, osteosarcoma and chondrocytes. The
scaffolds were first incubated with osteosarcoma cell line for the deposition of bone
mineral on the scaffold and later porcine chondrocytes were used to regenerate cartilage
tissue on top of these mineral deposited CHI-CaP scaffolds. The main objective of this
study was to understand the influence of CHI-CaP bead size on the porosity, swelling
ratio, mechanical strength, degradation, and neocartilage tissue formation.
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5.2
5.2.1

Methods
Scaffold fabrication
Porous cylindrical shaped composite chitosan calcium phosphate scaffolds were

fabricated using co-precipitation method as described previously by Chesnutt et al. [15].
Our study differs from Chesnutt et al. by using chitosan powder of 78.7% DDA, where
they used 92% for scaffold fabrication. In the current study, scaffolds with three different
bead sizes were fabricated. Bigger size beads were made by dripping the chitosan
calcium phosphate solution directly from the nozzle of a 30 ml syringe (no needle was
used). Medium size beads were made in the similar way but using an 18G needle [19].
Smaller size beads were made by using an 18G needle and by focusing a jet of air
directly at the tip of the needle in order to dislodge each CHI-CaP droplet from the needle
before it grows large enough to fall under its own weight. These beads were collected and
left in the precipitate solution, a mixture of methanol, NaOH, and water at a pH 13 for 24
h for the formation of hydroxyapatite [25]. The beads were then washed in DI water
regularly, until it reaches neutral pH. Beads were dried overnight and then fused into
cylindrical shape (6mm diameter and 7 mm height) using 2% acetic acid and dried
overnight. All the scaffolds were frozen at -20°C for 2 h and freeze dried overnight. All
the scaffolds designated for making biphasic constructs were soaked in 0.05% of type I
collagen from rat tail in PBS for 3 h and air dried overnight. The scaffolds were then gas
sterilized using ethylene oxide before cell seeding.
5.2.2

Porosity and swelling ratio
Three freeze dried scaffolds from each group were imaged using micro computed

tomography (microCT). After imaging, the same scaffolds were rehydrated in PBS for 24
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h at 37°C and imaged again under microCT. The images were reconstructed into a 3
dimensional model using scanIP software and masked depending on the density of the
material (grey scale). The dimensions of the scaffold and the volume of the mask covered
for each scaffold were recorded. Porosity of dry and hydrated scaffolds was calculated
using Equation 5.1, where va is the apparent volume of the scaffold calculated from
dimensions of the scaffold and vm is the volume of mask covered (volume of beads). The
swelling ratio was calculated as the percentage increase in mass upon rehydration for 24
h in PBS.
𝑣𝑎 −𝑣𝑚

𝑃=(
5.2.3

100

) 𝑣𝑎

(5.1)

Mechanical testing
One of the main functions of bone in in vivo is load bearing. As the scaffold

replaces the bone, compression modulus of the cell-free composite CHI-CaP scaffolds
were measured using Mach I. In order to measure the compressive modulus, six
scaffolds from each group were incubated for 24 h, 14 d, or 28 d in cell culture medium
at 37°C. Young’s modulus in the axial direction was determined by unconfined
compressive loading at 5 μms-1. The compression modulus was calculated from the slope
of stress-strain curve.
5.2.4

Degradation
Lysozyme is the enzyme that helps in chitosan degradation in in vivo. Three

scaffolds (6 mm diameter x 7 mm height) from each group were incubated at 37°C in
1mg/ml of lysozyme in PBS. The lysozyme solution was collected at every three-day
time interval and the scaffolds were dried completely until they attained stable weight
103

before adding fresh lysozyme solution. The lysozyme solution at every 3 d time interval
was used to measure the amount of calcium released into the solution based on
colorimetric assay using Calcium LiquiColor kit, Stanbio laboratory. Total dry weight
loss with respect to their initial dry weights was also calculated at each time point.
5.2.5

Mouse Osteosarcoma cell line
Osteosarcoma cells at 8th passage were obtained from another lab. These cells

were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) medium having 10%
fetal bovine serum (FBS) and 1% antibiotic and antimitotic factors (ABAM). When cells
reach 90% confluence, they were treated enzymatically with trypsin and seeded into new
flasks. Cells at tenth passage were used for this study.
5.2.6

Porcine chondrocytes
Chondrocytes were collected and cultured from femoral condyles of one healthy

matured pig. First, the articular cartilage tissue was carefully removed from the femoral
condyles and digested in DMEM containing 1% type 2 collagenase, 5% FBS, and 2%
ABAM for overnight at 37°C and 5% CO2. Cartilage tissue digestion solution was
filtered using a cell suspension filter and centrifuged at 500g for 5 min. The cell pellet
was then resuspended in DMEM containing 10% FBS and 1% ABAM and seeded in a
T175 cell culture flask. Before reaching confluence, cells were treated with trypsin and
subcultured into a new flask. Cells at second passage were used for making biphasic
constructs.
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5.2.7

Biphasic constructs
Twelve Freeze dried, collagen coated, and gas sterilized scaffolds of each bead

size were used for making biphasic constructs. Two scaffolds of same bead size were
incubated together in 10×106 cells/ml of tenth passage mouse osteosarcoma cell
suspension for 24 hours in a sterile 15ml centrifuge tube. The cell suspension in the tubes
was resuspended by slowly shaking the tube for every 15 min for 2 h to achieve
maximum cell attachment to the scaffolds. The scaffolds were then incubated in
osteogenic medium in a 6 well cell culture plate for 6 weeks, replacing medium every 4
days. At the end of 3 week and 6 week time period one scaffold from each group was
fixed in 2.5% glutaraldehyde for SEM. The remaining scaffolds were air dried for several
hours before seeding porcine chondrocytes. Each dried scaffold was placed in an
individual well of a 6 well plate and covered with 1.5% agarose in DMEM. Once the
agarose was gelled, 5mm hole was made on top of the scaffold using biopsy punch and
the agarose was removed using pasteur pipette. 3.5×106 of second passage porcine
chondrocytes suspended in 40µl of DMEM were then seeded on top of each scaffold
resting in an agarose well (Figure 5.1). Chondrocytes were allowed to settle for 30 min
and then the wells were flooded with defined chondrogenic medium (DCM). DCM
consisted of high glucose DMEM containing 1% ITS+Premix (BD Biosciences, San Jose,
CA), 0.1 mM dexamethasone, 50 µg/mL ascorbate-2 phosphate, 1 mM sodium pyruvate,
40 µg/mL L-proline, 1% antibiotic-antimycotic solution (Sigma-Aldrich, St. Louis, MO),
and 10 ng/ml human recombinant transforming growth factor-β3 (PeproTech, Rock Hill,
NJ) [26]. These biphasic constructs were cultured for 4 weeks in DCM, replacing
medium every 4 days. At the end of 4 weeks, the tissue formed on top of two biphasic
105

constructs of each group was slowly scrapped to see how well the tissue was adhered to
scaffold and the scaffolds were fixed in 2.5% glutaraldehyde for SEM. Three biphasic
constructs from each group with the tissue were also fixed in 2.5% glutaraldehyde for
SEM and microCT imaging.

Figure 5.1

5.2.8

Schematic representation of the formation of biphasic constructs using
collagen coated CHI-CaP scaffolds.

SEM sample preparation
The structure and the surface morphology of the cell free scaffolds, scaffolds with

osteosarcoma cells and final bipasic constructs were examined using a scanning electron
microscope (SEM). SEM gives a clear view of tissue covered on a scaffold. All the
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samples designated for SEM were fixed in 2.5% glutaraldehyde in PBS for overnight at
4°C. Later the scaffolds were dehydrated in graded ethanol (30%, 50%, 70%, and 90%)
for 20 minutes at room temperature. Scaffolds were finally incubated in two changes of
100% ethanol and hexamethyldisilazane for 20 minutes each, and air dried under hood
for about 30 minutes. These samples were then sputter coated with platinum and imaged
using a JEOL JSM-6500F Field Emission Scanning Electron Microscope.
5.2.9

Statistics
All the quantitative data reported were analyzed using turkey test in SPSS, and p-

values < 0.05 were considered as statistically significant (IBM SPSS statistics 23).
5.3
5.3.1

Results
Scaffold characteristics
Scaffolds with three different bead sizes were fabricated as mentioned earlier. The

diameter of big, medium, and small size beads were approximately 1.49±0.09 mm,
0.984±0.11 mm, and 0.76±0.06 mm respectively. The final dimensions of scaffolds in all
the groups were approximately 6 mm in diameter and 7 mm in height. SEM images of
cell free scaffolds showed a clear surface morphology of freeze dried CHI-CaP with
porous architecture (Figure 5.2, 5.3) and there was no difference in the surface
morphology between the three groups. The microCT images gave a clear view of the
bead size and porosity (Figure 5.4, 5.5). Porosity of dry and hydrated scaffolds of the big
bead size was greater than other two groups (Table 5.1). Pore sizes range from 250 to
1300 and 200 to 750 µm for big and small bead size scaffolds (Figure 5.6). Porosity of
dry and hydrated scaffolds of big size beads was significantly different from small size
107

beads. Swelling ratio, which was measured as the increase in mass upon rehydration was
also greater in bigger bead size scaffolds. No statistical difference was observed for
swelling ratio between the groups.

Figure 5.2

Scanning electron micrograph of a porous CHI-CaP scaffold formed by
fusing medium size beads using acetic acid.
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Junction between
two beads

Figure 5.3

Scanning electron micrograph showing the junction between two medium
size beads fused together.
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Figure 5.4

Micro computed tomography images of freeze dried CHI-CaP scaffolds
formed using three different bead sizes.
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Figure 5.5

Micro computed tomography images of freeze dried and hydrated CHI-CaP
scaffold formed using medium size beads.
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Table 5.1

Physical characteristics of CHI-CaP scaffolds formed using three different
bead sizes.
Characteristic

Big bead size

Medium

Small bead size

scaffold

bead size

scaffold

scaffold
Average bead size (n=25)(mm) 1.49±0.09A

0.984±0.11B

0.76±0.06C

Porosity of dry scaffold (%) 43.02±5.86A

34.24±4.50AB 30.29±3.20B

(n=3)
Porosity of hydrated scaffold 116.53±19.06A

85.26±9.61AB 73.09±5.60B

(%) (n=3)
Pore range of dry scaffold 250 – 1200A

200 – 900AB

200 – 750B

300 -1150AB

250 – 950B

(n=30) (µm)
Pore range of hydrated scaffold 400 – 1500A
(n=30) (µm)
Swelling ratio (%) (n=6)

94.28±2.80A

Increase in diameter after 24.15±1.72A

90.09±2.55AB 87.19±5.05B
22.71±1.53A

22.14±2.33A

after 24.08±3.02A

22.97±1.97A

22.41±1.38A

after 91.25±5.22A

85.23±6.51A

82.67±7.01A

hydrating (%) (n=6)
Increase

in

height

hydrating (%) (n=6)
Increase

in

volume

hydrating (%) (n=6)
(values= mean±stdev). Letters represent statisctical significance.

112

Figure 5.6

5.3.2

Histograms showing the pore size range in dry and hydrated CHI-CaP
scaffolds of different bead sizes.

Mechanical testing
The compressive modulus of CHI-CaP scaffolds rehydrated in culture medium for

24 h, 2 weeks and 4 weeks was measured by performing unconfined compression testing.
Results from mechanical testing revealed that the compression modulus for the small size
scaffolds rehydrated in culture medium for 4 weeks was higher (8.31±1.45) whereas the
bigger bead size scaffolds rehydrated for 2 weeks has the least (5.36±0.44) than all other
113

groups (Figure 5.7). The overall compressive modulus of big bead size scaffolds was
significantly lower from other groups, whereas no significant difference was noticed
between medium and small size groups. The hydrated scaffolds were not delicate and all
the scaffolds reached the end point without fracture. Scaffolds were more consolidated
and compacted while testing.

Figure 5.7

Compressive modulus of different bead size CHI-CaP scaffolds after
rehydrating in culture media for 24 h, 2 weeks or 4 weeks.

Letters represent the statistical significance at respective time period
5.3.3

Degradation
CHI-CaP scaffolds of different bead sizes were digested in 1mg/ml of lysozyme

solution in PBS. After every 3 day time interval, scaffolds were dried completely and
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weighed before adding fresh lysozyme solution. The rate of degradation was estimated
from the amount of calcium released into the solution and the weight loss with respect to
initial dry weight of the scaffolds. The amount of calcium released was significantly
increased with bead size with more calcium released from big size beads. The total
weight loss increased with an increase in bead size and a statistical increase was seen
from small to big size beads.

Figure 5.8

Total amount of calcium released after 3 d, 6 d, and 9 d of incubation in
lysozyme solution.

Letters represent statistical significance at respective time period.
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Figure 5.9

Average absolute weight loss with respect to initial weight after 3 d, 6 d,
and 9 d of incubation in lysozyme solution.

Letters represent statistical significance at respective time period.
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5.3.4

Biphasic constructs
Scaffolds with three different bead sizes were used to make biphasic constructs.

Scaffolds were first incubated in a mouse osteosarcoma cell line for 6 weeks. One
scaffold from each group was taken for SEM at 3 week and 6 week time periods. All the
scaffolds at the 3 week time period showed a huge mass of fibroblasts stretched over the
scafoold (Figure 5.10). SEM images at the 6 week time period showed more mineral
deposition compared to 3 week time period (Figure 5.11). SEM images of all the
scaffolds with mineral deposition were almost the same with no effect on bead size.
Porcine chondrocytes were then seeded on these mineral deposited scaffolds for
neocartilage formation. After culturing these biphasic constructs in DCM for 4 weeks, a
white cartilage like tissue was observed on all of the scaffolds macroscopically (Figure
5.13). The tissue formed was not uniform on big sized bead scaffolds when observed
macroscopically, but the SEM images showed neotissue covering the seeded area. Tissue
formed on two biphasic constructs of all bead sizes was slowly scrapped to see how well
the tissue was adhered. The tissue formed on all the groups adhered at almost same rate.
Small amounts of tissue remnants attached to scaffold after scrapping the tissue were
observed under SEM (Figure 5.14). SEM images of the final biphasic constructs showed
the presence of cartilage like tissue on the beads covering almost the whole chondrocyte
seeded area. One biphasic construct with osteosarcoma and chondrocytes was fixed in
2.5% glutaraldehyde and imaged under microCT image. The images were reconstructed
and masked depending on density (grey scale). The final images showed that in all the
three experimental groups, beads were covered with cellular material (mineral deposition
from osteosarcoma cell line) (Figure 5.15) but there is no clear separation of cellular
117

material from osteosarcoma and chondrocytes in big and small bead size scaffolds
(Figure 5.16). In medium size bead scaffolds, the area of chondrocytes seeded was clearly
noticeable (Figure 5.17).

Figure 5.10

SEM images showing fibroblast like cell coverage on big bead size CHICaP scaffolds after incubating scaffolds in osteosarcoma cell suspension
for 3 weeks.
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Figure 5.11

SEM images showing increased mineral deposition on big bead size CHICaP scaffolds after incubating scaffolds in osteosarcoma cell suspension
for 6 weeks.
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Figure 5.12

SEM image of a native clean bone.
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Figure 5.13

Side and top view of the medium bead size biphasic construct showing the
mineral deposition and neocartilage formation when dried using
hexamethyldisilazane for SEM.

121

Figure 5.14

Scanning electron micrographs of different bead size collagen coated CHICaP scaffolds showing the neotissue formed using porcine chondrocytes
and the remnants after scrapping the tissue.
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Figure 5.15

microCT images of medium size biphasic constructs

A-C) three different axis with green representing the cellular material, D-F) three
different axis with red representing scaffold beads and green as cellular material, G)
3dimensional view only cellular material, H) 3 dimensional view of scaffold without
cellular material, I) 3 dimensional view showing cellular material completely covering
the scaffold.
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Figure 5.16

Top view microCT images of the bipahsic constructs formed using CHICaP scaffolds and osteosarcoma and chondrocytes.

Figure 5.17

Side and top view of the microCT images of medium bead size biphasic
constructs,

Biphasic constructs show that the scaffold beads (shown in red) were completely covered
by cellular material (green) and clearly distinguishes the chondrocyte seeded area.
5.4

Discussion
In the current study, biphasic constructs were formed using CHI-CaP scaffolds

and osteoscarcoma cell line and chondrocytes. In this biphasic approach, scaffold with
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osteosarcoma cellular material represents a bony phase, while the neocartilage formed
from porcine chondrocytes represents the cartilage phase. Mouse osteosarcoma cells were
used for the bone mineral deposition on scaffolds prior to the formation of neocartilage.
The porous CHI-CaP scaffolds fabricated in this study were similar to the method
proposed by Chesnutt et al. [15] but chitosan with lower DDA was used in this study and
our scaffolds faced an extra freeze drying step, which was known to increase the porosity
of the scaffolds [6]. In the current study, scaffolds with three different bead sizes were
fabricated and scaffold characteristics, and tissue formation were compared among the
scaffolds.
CHI-CaP scaffolds of three different bead sizes were fabricated in this study by
varying the CHI-CaP droplet size. Porous structure of the scaffolds was made by fusing
individual beads using 2% acetic acid. Porosity plays an important role in scaffold design
and architecture where it influences the mechanical strength, degradation, and tissue
formation on the scaffold. Previous studies have shown that porous structure with highly
interconnected pores is necessary for bone growth and vascularization [27,28]. microCT
images of all the three bead size scaffolds confirmed interconnected pores, but the pore
range for big size beads was more (250-1200 µm). Scaffolds with pore ranging from 100800 µm are sufficient for tissue growth [29]. The main disadvantage of the large pore size
is that the chondrocytes seeded for cartilage regeneration will make their way into the
scaffold rather than adhering and forming a tissue on top of the scaffold. A significant
difference in the porosity values was observed between big and small size beads. The
porosity of small size scaffold was in the lower range of porosity, whereas the porosity of
big size beads was more than needed for tissue growth in vivo [29,30]. The porosity of
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medium size scaffolds was same as shown by Chesnutt et al. [15] and it was also shown
that scaffolds of this porosity helps in cartilage tissue formation on CHI-CaP scaffolds
[19]. A previous study has shown pore size ranging from 100- 800 µm is sufficient for
new tissue formation [29].
The overall compressive modulus was significantly lower in big bead size
scaffolds than other groups. Mechanical strength of the scaffolds was affected by porosity
which in turn was affected by bead size of the scaffolds. It was shown that the scaffolds
with greater porosity have less mechanical strength and the scaffolds with lower porosity
have greater mechanical strength [31,32]. CHI-CaP scaffolds will be replacing a bone
defect in in vivo; therefore, they need to possess mechanical integrity until the new bone
formation takes place. The compressive modulus of small size beads at 4 weeks’ time
period was higher than all the groups, but the porosity of small size beads was smaller
which leads to poor tissue growth. The compressive modulus of all the group scaffolds
was close and approaching the lower range of human cancellous bone modulus that is in
the range of 10-2000 MPa [33].
In the current study, biodegradable CHI-CaP scaffolds, replaces the defected
subchondral bone region. Ideally these scaffolds will degrade as the new bone formation
takes place. Lysozyme was the enzyme that plays an important role in chitosan
degradation [34]. The amount of calcium released is close but smaller than the values
reported by Chesnutt but the percentage of weight loss was observed more in big and
medium bead size scaffolds than the values reported by Chesnutt [15]. The average
weight loss by big bead size scaffolds was greater than other groups, which might be due
to large pore size and porosity. The rate of degradation will depend on several factors like
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– DDA, crystalline nature, and pore size [15,35,36]. Previous studies have shown that
chitosan with higher DDA degrades slower than the chitosan with lower DDA [15,37,38].
SEM images of cell free scaffolds were same for all the three groups except the
bead size and pore size. TEM images of similar type of scaffolds showed regular
distribution of calcium and phosphate crystals in the scaffold [15]. SEM images of
scaffolds with osteosarcoma cells were also same at 3 week and 6 week time periods,
with more mineral deposition at 6 weeks. Chondrocytes were cultured for 4 weeks on
mineral deposited CHI-CaP scaffolds. The tissue formed from chondrocytes on medium
sized scaffolds was more distinctive than the other groups, which was also evidenced in
microCT images. The chondrocytes seeded on big size beads might passed through the
pores and settled somewhere in the scaffold due to the high porous nature of those
scaffolds. On the other hand, the porosity of the small size scaffolds was in the lower
range of required porosity, which made the insufficient nutrient and waste material
diffusion through the pores.
In this study, the effect of CHI-CaP bead size was clearly studied from porosity,
pore sizes, mechanical strength, swelling ratio, degradation, and neocartilage tissue
formation. Medium size beads with an average diameter of 0.984±0.11 mm were found to
be the best bead size with approximately 34% porosity. Even the mechanical strength of
medium size beads was less than the small size beads, but there was no statistical
difference. Coating the scaffolds with collagen type I increased cell adhesion which was
seen in SEM of biphasic constructs after scrapping the tissue. The main limitation in this
study would be the cartilage formation was restricted to 5mm diameter on top of CHICaP scaffold. In order to implant these scaffolds, cartilage tissue needs to cover the whole
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top surface of the scaffold. More significant values in scaffold characteristics – porosity,
degradation, and mechanical strength can be obtained when a larger sample size was
used. In the current study we mainly concentrated on identifying the effect of bead sizes
but we did not perform many studies to see the phenotype of the cartilage tissue formed.
But a previous study has shown that chondrocytes seeded on top on CHI-CaP scaffolds
lead to the formation of cartilage like tissue after 4 weeks culture in DCM [16].
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SUMMARY

6.1

Summary
The main goal of this dissertation was to form a scaffold-free cartilage tissue on

top of biodegradable chitosan calcium phosphate scaffolds for osteochondral defects.
Microbeads were made by co-precipitating chitosan with calcium and phosphate. These
beads were fused together to form a cylindrical shaped scaffolds with sufficient
mechanical strength and porosity for tissue ingrowth. This study exhibited attachment
and proliferation of mesenchymal stem cells and chondrocytes. Two different approaches
for making biphasic constructs were analyzed and the approach where cells were in direct
contact with the nutrients in cell culture media has shown better results.
Cell attachment to these porous CHI-CaP scaffolds has been a major problem. To
overcome this, freeze dried scaffolds were coated with type I collagen protein. Coating
the scaffolds with an extracellular matrix protein increased cell attachment and
proliferation of mesenchymal stem cells. The neocartilage formed on coated scaffolds
was similar to native cartilage in collagen architecture. Biphasic cartilage/CHI-CaP
constructs were successfully created by high-density seeding of human bone marrow
mesenchymal stem cells onto coated scaffolds. The attachment of mesenchymal stem
cells to especially type I collagen is mediated by α1β2, α2β1, and α11β1 integrins. This
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type of collagen coating would enhance MSC adhesion which improves the performance
of chitosan based scaffolds for various applications.
In this study, the bone like cells were initially cultured on scaffold to precondition
the scaffold prior to chondrogenic culture. This helps in easy bone formation and
vascularization when implanted in the defect site. Individual bead size of these scaffolds
plays an important role in porosity, which affects the mechanical strength, degradation,
and tissue formation on scaffolds. Scaffolds were fabricated with different bead sizes and
a cartilage-like tissue was formed on biphasic constructs using porcine osteosarcoma
cells and porcine chondrocytes. The studies showed that sufficient porosity of the
scaffolds was needed to support mechanical integrity, rate of degradation, and tissue
ingrowth. This study showed that the scaffolds fabricated with medium size beads had
ideal porosity, pore size, and with a distinctive cartilage formation compared to other two
bead sizes.
All the studies conducted to date have shown the potential of using composite
chitosan calcium phosphate scaffolds to support formation of a layer of cartilage through
high-density cell seeding for osteochondral defects. But, there were two main limitations
of this study using chitosan with approximately 78% DDA. Despite some encouraging
mechanical results, the beads do not always stay tightly fused and the scaffolds tend to
fall apart with repeated handling and after storage. This was also observed in the in vivo
study, where these biphasic constructs formed using rabbit bone marrow derived
mesenchymal stem cells and medium bead size scaffolds were tightly fit into surgically
created defects in the stifle joints of skeletally matured rabbits. In a study Jana et al.
fabricated scaffolds using pristine chitosan dissolved in acetic acid at higher
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concentrations, showed increased mechanical properties [1]. Secondly, the rate of
degradation, although there was a measurable amount of calcium released and weight
loss, but the total scaffold degradation time was too slow. A previous study also showed
that chitosan with carboxymethyl groups and using a ratio of high to low molecular
weight chitosan for scaffold fabrication would help the scaffolds to degrade faster than
using an original chitosan scaffold [2].
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